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INTRODUCTION 
This dissertation project sought to determine the relationship between 
function and structure of the transmitter domain of the chemotaxis-associated 
histidine autokinase CheA of Eschericia coli. For some time, the transmitter 
domain of CheA has been proposed as the site of ATP binding and hydrolysis 
on the basis of homology to eukaryotic serine/threonine kinases. Here, I have 
tested this hypothesis, establishing that the transmitter region of CheA does act 
as the catalytic site. 
First, I used site-directed mutagenesis to introduce conservative amino 
acid changes in the highly conserved regions of the putative catalytic domain of 
CheA. I then examined their ability to mediate chemotaxis and in the process 
demonstrated that changes in the most conserved residues of this domain 
completely eliminated chemotaxis. 
Second, I purified these mutant CheA proteins and tested their ability to 
autophosphorylate (a measure of their capacity to bind and hydrolyze ATP). 
None of the CheA mutants tested autophosphorylated despite prolonged 
exposure to ATP. In collaboration with Rick Stewart (University of Maryland), 
we next determined that a CheA protein mutated in the first of two glycine-rich 
1 
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regions bound the ADP analog TNP-ADP poorly ie., with about a 10-fold 
decrease in affinity relative to that of the wild-type protein. In contrast, a CheA 
protein mutated in the second glycine-rich regions bound TNP-ADP about as 
well as did the wild-type CheA protein. Although point mutations within this 
second glycine-rich region exerted no effect upon its ability to bind TNP-ADP, 
eliminating the entire region caused about a 3-fold decrease in affinity. A 
protein mutated in both glycine-rich regions bound TNP-ADP about 2 times less 
efficiently than did a protein mutated in the first glycine-rich region.Thus, 
although this region may not play a direct role in binding TNP-ADP, it does 
influence binding by the first glycine-rich region. 
Third, I examined each of the mutants for their ability to be complemented 
with an intact putative catalytic domain supplied in trans by CheA8 , a natural 
variant of CheA that lacks the site of autophosphorylation. In vitro, CheA8 
complemented all of the CheA mutants tested. In vivo, CheA8 complemented 
CheA proteins mutated in either of the glycine-rich regions, but not those 
defective in both of the glycine-rich regions or deleted for the second one. 
Since transphosphorylation in vitro of these latter two mutant proteins was 
significantly reduced relative to that of mutants defective for one glycine-rich 
region or the other, these results support the hypothesis that CheA 
autophosphorylation must reach a certain threshold level before chemotaxis 
can occur in vivo. CheA proteins mutated in G 1 or G2 cannot complement each 
other in vivo or transphosphorylate each other in vitro suggesting that the G 1-
F-G2 regions in a CheA dimer function independently and in cis within each 
protomer. 
3 
Fourth, I examined the putative catalytic domain of CheA with computer 
algorithms designed to predict secondary structure. On the basis of these 
structure-averaging algorithms, I propose that the catalytic region might best be 
represented as a cleft in which the F subdomain lies at the base and acts as a 
flexible turn or hinge flanked by two short alpha helices. This arrangement 
would serve to approximate G1 and G2, predicted to be unstructured 
ATP-binding loops. The binding of ligand by the chemoreceptor would initiate a 
cascade through the ternary complex with the end result being the movement of 
the G 1 and G2 loops apart, rendering CheA in an "open" or inactive 
conformation (Fig 20). To test this hypothesis, NMR analysis and x-ray 
crystallographic analysis is required. 
CHAPTER2 
LITERATURE REVIEW 
Sense and Response 
All of life is connected by common needs. Among life's enormous 
divergence, there exist fundamental systems and behaviors which bind the 
simplest to the most complex. For instance, to survive and prosper, all cells, 
from the simplest form of bacteria to the most complicated eukaryote, must 
perform two tasks very well. First, they must sense their environment. Second, 
they must be able to respond to what they sense. 
A eukaryotic cell senses its environment primarily through the use of 
proteins located on its surface and within its interior. Messages from the 
exterior of the cell are conveyed to the interior by physical interaction of the cell 
surface proteins with cytoplasmic proteins and with other cell surface proteins. 
Although simple in comparison to eukaryotic cells, bacteria sense their 
environment in much the same way. 
The life of a bacterial cell is a precarious one. It must live in an 
environment which is often hostile and dangerous, requiring that it respond 
rapidly to unexpected extremes of nutrient supply, temperature, pH, and acidity. 
4 
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Bacteria are particularly adept at adapting to extremes. In fact, bacteria have 
been so successful at adaptation, that they survive in a wide range of 
environments that would be much too extreme for most eukaryotic cells. For 
example, bacterial cells have been found thriving in the cooling tanks of nuclear 
reactors and in super hot volcanic vents. To cope with such extremes, bacteria 
have developed a wide array of specialized systems for sensing, interpreting 
and responding to changes in their extracellular environment. They have 
evolved a range of complex responses to environmental stresses. One such 
response occurs when an E. coli cell encounters an increase in osmolarity of 
the surrounding environment. In response, an inner membrane protein called 
EnvZ autophosphorylates before passing that phosphate to a cytoplasmic 
protein (OmpR). In its phosphorylated state, OmpR binds DNA, increasing 
transcription of one outer membrane porin and decreasing that of another. This 
response allows the cell to optimize its internal salt concentration (Alphen and 
Lugtengerg, 1977; Forst and Inouye, 1988). Phosphorylated OmpR also 
influences the expression of the entire flagellar regulon (Shin and Park, 1995). 
The response could also be far more complex, such as the formation of spores 
by Bacillus subtilis (Burbulys et al., 1991 ), fruiting body formation in 
microorganisms such as Myxococcus xanthus (Zusman and McBride, 1991), or 
the chemotactic response by Eschericia coli (Mutoh and Simon, 1986). 
Chemotaxis and the Flagellum in Eschericia coli 
Chemotaxis is the process whereby a bacterium senses the presence of 
attractants or repellents in its environment and responds by altering its 
6 
swimming behavior. Some cells sense and respond to the concentration of 
attractant in a highly directional manner, basing its direction of movement upon 
where the stimulus occurred on the surface of the cell. Lymphocytes of the 
mammalian immune system move in this fashion, altering their direction of 
movement toward the point of the stimulus in the cellular membrane. This type 
of "spatial" sensing relies upon the cells ability to calculate the difference in the 
concentration of attractant at the point of the stimulus from the concentration of 
attractant at a point opposite the stimulus and modify its direction accordingly. 
A bacterium such as E. coli , however, senses the concentration of attractants 
continuously in a temporal rather than spatial manner (Macnab and Koshland, 
1972). An E. coli cell must sense temporally both because of its small size and 
because it can sense changes in ligand concentration even when the 
concentration of ligand is spatially homogeneous (Berg and Purcell, 1977; 
Macnab and Koshland, 1972). This type of sensing is non-directional: it does 
not matter if the attractant is being sensed at one end of the cell versus the 
other. If attractants were sensed spatially by E. coli, the origin of the stimulus 
would always point in the direction of swimming. 
E. coli swims in a fluid environment by the use of propellor-like structures 
called flagella. At the base of each flagellum is a motor that rotates alternately 
counterclockwise (CCW) and clockwise (CW). Because of the shape and 
periodicity of its flagella, E. coli is able to bundle all of its flagella into a single 
helical unit which works in concert to propel the cell forward in a smooth gently 
ccw 
RUN 
cw 
TUVIBLE 
( 
I 
Fig 1. The "run" and "tumble" response. Illustration of the 
relationship between direction of flagellar rotation and swimming 
behaviors displayed by cells of E. coli. Counterclockwise (CCW) 
rotation corresponds to runs; clockwise (CW) _rotation corresponds 
to tumbles. 
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curving path called a "run". This behavior occurs when the motors rotate CCW. 
The cell changes direction by simply reversing some of its motors, causing them 
to rotate in the CW direction. This action causes the flagellar bundle to jam, the 
flagella fly apart and, working at cross-purposes, the cell executes a flailing 
behavior called a ''tumble" until the motors re-assume the CCW direction of 
rotation causing the bundle to reform (Fig. 1 ). 
How does an E coli cell use seemingly random tumbles to swim toward 
a better life? E. coli is an "optimist" and is constantly in search of a "better life" 
(Berg 1983). When swimming in a liquid environment, et is constantly sensing 
and calculating the concentration of attractants and repellents it encounters 
(Berg and Purcell 1977). When the cell swims up a gradient of attractant, it 
suppresses the next tumble. By contrast, if it swims down that gradient, the next 
tumble occurs. Thus, runs in favorable directions are twice as long as those in 
unfavorable directions. 
The Flagellar Complex 
E. coli is an enteric organism of the human gut, where it exists in a 
commensal relationship with its host. The digestive tract of humans is limited in 
its ability to break down many nutrients. Bacteria serve as an aid to promote 
conversion of many indigestible nutrients into forms the host can metabolize. 
Chemotaxis is an expensive undertaking in the context of energy consumption. 
The energy expenditure is, however, justifiable under a variety of conditions. In 
the environment external to the host, the flagellar complex may be needed for 
9 
Fig 2. The flagellar complex. (Adapted from Macnab, 1996) 
10 
the purpose of finding nutrients and escaping toxins. But, in the nutrient-rich 
environment of the gut, a flagellated cell may act as a virulence factor, 
facilitating attachment and entry into preferred environments. When it becomes 
necessary to produce a flagellum, E. coli initiates, through a number of 
operons, the coordinate synthesis of all of the components necessary for its 
construction. The flagellum is a complex structure that can be divided into three 
main structural components; the extended basal body, the hook, and the 
filament. Expression of the flagellar genes is performed in a hierarchical 
fashion (Kutsukake and lino, 1994., Macnab, 1992). The actual assembly of the 
flagellum is conducted sequentially with the basal body being constructed first, 
followed by the hook, and then the filament (Fig 2). 
The basal body : The basal body traverses the inner and outer 
membranes and is anchored to the rigid cell wall. Elegant isolation techniques 
and electron microscopic studies have revealed a structurally complex 
organelle composed of a number of distinct structural features. The extended 
basal body is the portion of the organelle lying on the inside of the inner 
membrane and is called the "C" ring. This ring, composed of three proteins 
called FliG, FliM, and FliN, is the switching apparatus responsible for 
controlling rotational direction of the motor. This switch in direction is made in 
response to interaction with the phosphorylated chemotaxis protein CheY, 
described below (Francis et al., 1994). 
The parts of the flagellar motor that comprise the actual turning apparatus 
of the flagellar motor is composed of a number of interacting structural 
1 1 
components Above the C ring and traversing the inner membrane, cell wall, 
and outer membrane are the MS ring (FliF), the proximal rod (FliB, FlgC, and 
FlgF), the P and L rings (Flgl and FlgH), and the distal rod. The MS ring and the 
Rod are spinning regions of the motor, while the L and P rings are thought to 
act as a sort of flange, anchoring the basal body to the cell wall. 
MotA and MotB: The flagellar motor is driven by proton motive force. 
The protons needed to rotate the motor are supplied via a proton channel 
composed of two proteins called MotA and MotB (Zhou et al., 1995). Mutants 
in the Mot proteins are characterized as "paralyzed", meaning the motor does 
not spin. This suggests that these proteins are directly involved in conduction of 
protons across the membrane to drive the motor (Blair and Berg, 1990; Block 
and Berg, 1984). Although not an integral part of the basal body structure, MotA 
and MotB surround the basal body. They act as the stator for the flagellar motor 
and are essential for motility. Both proteins span the entire inner membrane. 
Whereas MotA contains a substantial cytoplasmic interface, MotB contains a 
peptidoglycan binding domain (Dean et al., 1984). The precise mechanism of 
proton movement through the channel is not known. However, several residues 
critical to channeling protons through MotA and MotB have been identified 
(Sharp et al., 1995; De Mot and Vanderleyden, 1994). 
The hook: The hook (FlgE) assembly is a highly flexible link between 
the basal body and the filament. Its function is similar to that of a U-joint on a 
car. The hook both allows the filament to rotate on a different plane than the 
basal body motor and allows several flagella to bundle into a uniform complex. 
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The helical wavelength of the hook is different from that of the filament despite 
having the same nine fibril structure (Morgan et al., 1993). This allows flexibility 
not possible with the more rigid filament structure (Block et al., 1989; Block et 
al., 1991 ). Without this important component, all of the flagellar components 
would have to be located within a small region to enable the flagella to form a 
bundle. 
The filament: The filament is the structural assembly which acts like a 
propeller, giving the cell the ability to swim through a fluid environment. This 
structure is composed entirely of a single protein subunit called flagellin (FliC) 
(Kuwajima et al., 1986). When observed at high magnification, the filament can 
be seen to possess a periodicity (a sine wave pattern) of about 0.5 µm (Kamiya 
et al., 1982). When the motor is rotating in its default CCW direction, the flagella 
group together in a single bundle and allow the cell to swim in a forward 
direction. 
The Chemotaxis Pathway 
Chemotaxis in E coli and other microorganisms is dependent upon the 
ability of chemoreceptors to communicate with switch components of flagellar 
motors to modulate swimming behavior in response to the cells' chemical 
environment. This communication requires the cooperative effort of the 
cytoplasmic gene products of six genes, cheW, cheR, cheB, cheY, cheZ and 
cheA (Mutoh and Simon 1986; Stock and Stock, 1987). Additionally, E coli 
encodes 5 transmembrane chemoreceptors also known as transducers or 
methyl-accepting chemotaxis proteins (MCP's). They are Tar (Clark and 
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Koshland, 1979), Tsr (Hedblom and Adler, 1980), Tap (Manson et al., 1986), 
Trg (Adler et al., 1973), and the recently described Aer (aerotaxis) (Bibikov and 
Parkinson, Johnson and Taylor, personal communication). Tar and Tsr, the two 
most extensively studied chemoreceptors, sense the amino acids aspartate and 
serine, respectively. 
The Excitatory Response 
Chemotaxis is typically discussed in terms of two response mechanisms, 
excitation and adaptation. When cells determine that the concentration of 
attractant has increased or the concentration of repellent has decreased, they 
respond by increasing the length of their runs. This behavior is called the 
excitatory response. Even though the stimulus might persist, the excitatory 
response lasts only seconds before the cell returns to its baseline behavior. 
The return to baseline behavior occurs because of the adaptation response. 
Both excitation and adaptation occur in response to signals generated by 
an inner membrane-bound ternary complex composed of an MCP dimer, a 
CheA dimer, and two CheW monomers (Fig 3). This ternary complex relays 
information concerning ligand concentration from the outside to the inside of the 
cell. 
The chemoreceptors: The MCPs are located within the inner 
membrane. They are composed of a highly variable periplasmic domain, a 
transmembrane region, and a largely conserved cytoplasmic domain. The 
degree of conservation among these-different domains speaks to their 
respective functions. The periplasmic domains are variable since they bind 
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Fig 3. Orcuitry of the chemotactc signal transduction pathway. Chemoreceptors 
(MCP) located in the inner membrane transduce signals from the periplagn to OleAL (AL) 
or CheAs (As) through the roupling protein CheW ~). CheAautopho~horylates in 
response to a decrease in concentration of ligand (Table 1), and, in turn, pho~horylates 
the response regulator CheY (Y). Alospho-CheY then interacts with tte flag3llar motor 
to change the drection of 10tation from CCW to CW. The phmphatase CheZ (Z) 
dephosphorylates CheY. The chemoreceptor adapts to lgand roncentration via receptor 
methylation/demethylation. The93 reactions involve the meth~transferase CheR (R) 
and the meth~esterase CheB (8). 
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different ligands (Table 1 ). The conservation of the cytoplasmic domain is 
necessary because the same internal signal is initiated in response to different 
stimuli. In addition, there are two transmembrane regions termed TM1 and TM2 
which flank a central, periplasmic ligand binding domain. TM2 is followed by a 
linker region which is connected to signaling domain by a short, helical 
methylated segment called MH1. The signaling domain is, in turn, followed by 
another methylated region called MH2. MH1 and MH2 serve as the 
methyl-accepting regions involved in the adaptation response described below. 
The cytoplasmic domain is also known as the signalling domain (Ames and 
Parkinson, 1994). It is thought that this region transfers the ligand signal from 
the periplasmic domain into a coupling protein called CheW which then 
transfers this signal into the histidine kinase CheA. 
CheW: CheW (14 kDa) couples the signal from the transducer to the 
histidine kinase CheA (described in detail below). While the nature of CheW's 
MCP-CheA coupling remains elusive, the sites of interaction with CheA and Tsr 
have been well characterized (Bourret et al., 1993). Analysis of second-site 
repressors of mutations in the chemoreceptor suggest that the signaling region 
of the chemoreceptor is the site of interaction with CheW ( Liu and Parkinson, 
1991 ). 
CheY: Signal transduction through the chemotaxis pathway is 
accomplished via the phosphorylation cascade CheA-P + CheY-> CheA + 
CheY-P (Fig 4). CheY (14 kDa), the response regulator of the CheA-CheY 
Table 1.--Ligands of the four known methyl-accepting 
chemotaxis proteins. 
MCP Attractant/Repellent 
Tsr Serine, Alanine, Glycerol/Leucine 
Tar Aspartate, Glutamate/ Ni2+,Co2+ 
Tap Di peptides/Phenol 
Trg Galactose, Glucose 
Aer Oxygen 
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two-component chemotaxis signal transduction pathway, is a phospho-protein 
which, in its phosphorylated form, interacts with the flagellar protein FliM, 
eliciting a change in direction of the flagellar motor. 
CheZ: CheY is an autophosphatase, with a phospho-aspartate half-life 
of only a few seconds. Despite this instability, the rate of spontaneous 
dephosphorylation roughly equals that of the rate of phosphorylation. Clearly, 
CheY needs a phosphatase to increase the rate of CheY-P degradation. CheZ 
(24 kDa) dramatically enhances CheY dephosphorylation. It binds CheY and 
presumably forces a conformational change in CheY that facilitates its transition 
to a dephosphoryated state (Blat and Eisenbach, 1994; Lukat et al., 1991 ). 
The Adaptation Response 
The adaptation response functions to maintain the MCPs in a constant 
state of readiness so that they may respond to slight alterations in the 
17 
p•~oo+ ~ CheV ~ o-o-c=]][[JOO + ~p•-~ Che A CheY-P* 
Fig 4. Transfer of phosphate (P*) from the sensor CheA to the response 
regulator CheY. For details concerning the domain organization of CheA, 
see Fig 5. 
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concentration of attractant or repellent. For instance, when an E. coli cell is 
swimming, the surrounding medium contains fluctuations in the concentration of 
attractant. In order to swim in a direction in which life is "better'', E. coli must be 
able to sense the presence of a gradiant of the attractant. By fluctuating 
between a methylated and unmethylated state, the chemoreceptor "adapts" to 
the homogeneity of attractant or repellant in the surrounding medium. In this 
way, the chemoreceptor "fine tunes" itself and filters out extraneous noise 
caused by homogeneous concentrations of attractant or repellant. The MCP 
adapts to attractant or repellant concentration by the action of two proteins, a 
methyltransferase (CheR) and a methylesterase (CheB). 
CheR: CheR (30kDa) is a methyltransferase which functions in the 
chemotactic adaptive response. Its purpose is to methylate glutamate residues 
located in the MH1 and MH2 regions of the cytoplasmic side of the 
chemoreceptors. CheR accomplishes this by transfer of a methyl group from the 
methyl donor AdoMet to the glutamate residues. The degree of strength of 
signal through the chemoreceptor correlates with the degree of methylation at 
the glutamate residues. Increases in the amount of methylation causes an 
increase in rate of CheA autophosphorylation within the ternary complex 
(Borczuk et al., 1986; Ninfa et al., 1991). Methylation seems to help regulate the 
signaling domain of the chemoreceptor by conformational changes in the 
MH1/MH2 regions. The region containing the glutamate residues has been 
elegantly shown to be a coiled structure whose torsional state has a 
tremendous effect upon the ability of the transducer to transfer a signal to CheA 
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(Cochran and Kim, 1996). In other words, as CheR-mediated methylation 
proceeds from zero residues to one residue and so on, the magnitude of signal 
amplification through the transducer increases. 
CheB: CheB (37kDa) is a methylesterase which also functions within 
the chemotactic adaptation response. Its purpose is to de-methylate/de-amidate 
the glutamate residues and counter methyltransferase-mediated signal 
enhancement by CheR. In addition to CheY and the periplasmic domain of Tar, 
CheB is the only other chemotaxis protein for which crystallographic data exists. 
In addition to CheY, CheB is the only other known protein to be phosphorylated 
by CheA. The donation of a phosphate to CheB results in activation of this 
protein. An increase in autophosphorylation of CheA leads to an increase in 
phosphorylation of CheB and subsequent demethylation of the 
chemoreceptors. 
Structurally, CheB is a monomer with regulatory and catalytic domains 
separated by a linker. The regulatory domain of CheB contains the 
phospho-acceptor site and is homologous to the response regulator CheY 
(Lupas and Stock, 1989; Stock et al., Cold Spring Harbor Symposium 1988). 
Phosphorylation of this domain increases the methylesterase activity of CheB 
over 10 fold (Stock et al., 1985). The catalytic domain of CheB has been 
revealed to be a wound a/B structure with seven a/B strands (West et al., 1995) 
The adaptation response in chemotaxis functions to ''fine tune" the ternary 
complex, dampening the effects of extremes of ligand availability. High levels of 
methylation activate CheA and low levels inactivate CheA. High levels of 
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methylation decrease the affinity of the chemoreceptor for its ligand (Yonekawa 
and Hayashi, 1986). So, in low levels of ligand concentration, CheR mediates 
methylation of the chemoreceptor which brings about activation of CheA and 
decreased affinity for ligand. Activated CheA phosphorylates CheB, which, in 
turn, demethylates the chemoreceptor, bringing about an increased affinity for 
ligand. Extreme levels of demethylation causes a decrease in CheA activity, 
again decreasing ligand affinity and shutting off the ternary complex. A middle 
ground, in which the chemoreceptor is only partially methylated is the ideal 
balance sought by the adaptation system. The ternary complex of 
CheA/CheW/chemoreceptor exists in a flux between an "on" and an "off' 
position. The methylation/demethylation system serves to stabilize the ternary 
complex into a state which can respond appropriately to subtle changes in 
ligand concentration (Stock and Surrette, 1994). 
Functional Organization of CheA 
Of the six chemotaxis genes, cheA, the primary focus of this study, is the 
most central because it serves as a phospho-donor to both Che Y, the excitatory 
signal, and CheB, the adaptive signal. The cheA gene encodes two proteins, 
CheAL (78 kDa) and CheA8 (69 kDa), translated in-frame from two different 
initiation sites (Parkinson and Kofoid, 1992; Smith and Parkinson, 1980) (Fig 5). 
Both proteins are histidine kinases of the two-component family (Stock et al., 
1985). 
Like other two-component histidine kinases, CheA functions as a dimer 
(Gegner and Dahlquist 1991 ). The two-component histidine kinase CheAL 
autophosphorylates a conserved histidine residue (His-48) located near its 
amino-terminus (Hess et al., 1988). Phosphorylated-CheAL' in turn, acts as a 
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phospho-donor for two other chemotaxis proteins: CheY, required for clockwise 
signal generation, and CheB, required for adaptation (reviewed in Bourrett et 
al., 1991; Stock et al., 1991; Stock and Surette, 1994). CheAL homodimers form 
ternary complexes with CheW and chemoreceptors, e.g., Tar (Gegner et al., 
1992). Within these complexes, the autokinase activity of CheAL is 
significantly accelerated relative to that of CheAL homodimers alone. Binding of 
ligand to the transducer protein, e.g., the Tar-specific attractant L-aspartate, 
greatly diminishes CheAL autokinase activity (Borkovich et al., 1989; Borkovich 
and Simon 1991; Ninfa et al., 1991 ). Thus, CheW and chemoreceptors 
modulate CheAL autokinase activity in a ligand-dependent manner. 
Although CheA8 lacks the site of autophosphorylation, it retains domains 
that in CheAL are required for kinase activity, ternary complex formation and 
phospho-transfer to CheY and CheB (Bourret et al., 1993; Hess et al., 1988; 
Kofoid and Parkinson 1988; Morrison and Parkinson 1994; Swanson et al., 
1993). Evidence, obtained in vivo and in vitro, indicates that the CheAL 
domains responsible for kinase activity and ternary complex formation also 
function in CheA8 . In vitro, CheA8 mediates receptor-modulated 
transphosphorylation of mutant CheAL proteins either deficient for kinase 
CheA._ N-
Che,¾, 
Fig 5. The domain organization of the two forms of CheA. Both forms of 
CheA are expressed in-frame from alternate translational start sites. P1 
contains the site of autophosphorylation (H), P2 is the CheY binding 
domain, TL is the site of CheA dimerization, TR contains the putative 
catalytic subunits, M and C couple CheA to CheW and chemoreceptor. 
The rectangles in TR represent highly conserved sequences. 
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activity or truncated for the carboxy-terminal segments required for ternary 
complex formation (Swanson et al., 1993; Wolfe et al., 1994; Wolfe and Stewart 
1993). In vivo, CheA8 restores chemotactic ability to cells that express either 
kinase-deficient or truncated CheAL mutant proteins (Wolfe et al., 1994; Wolfe 
and Stewart 1993). 
CheAL and CheA8 are composed of several distinct functional domains 
(reviewed in Kofoid and Parkinson 1988; Fig 5). Two of these domains, P1 and 
P2, located at the amino-terminus of the protein, are separated by a stretch of 
amino acids that resemble charge-rich linkers found in other regulatory and 
sensory transduction proteins (Parkinson and Kofoid 1992; Wooten and 
Drummond, 1989.). P1 contains the site of autophosphorylation, His-48 (Hess 
et al., 1988). This domain, present in CheAL but not in CheA8, is required for 
phospho-transfer to CheY and CheB (Swanson et al., 1993). P2 likely assists in 
the interaction between the phospho-donor site in P1 and amino acid 
sequences located in CheY (Morrison and Parkinson 1994; Swanson et al., 
1993). Two other domains, M and C, located at the carboxy-terminus, appear to 
play important roles in enabling CheAL and/or CheA8 to receive sensory 
information from the chemoreceptors (Bourret et al., 1993; Parkinson and 
Kofoid, 1992). 
Histidine Kinases 
Over 100 histidine kinases have been identified to date (Russo and 
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Silhavy, 1993; Parkinson and Kofoid, 1992; and Stock et al., 1989). The 
histidine kinases are linked into a family by virtue of 5 highly conserved 
subdomains termed H, N, G1 (D), F, and G2(G). CheA is atypical of most 
histidine kinases in that the H subdomain is located in P1, far removed from the 
other conserved subdomains. The N, G1, F, and G2 subdomains, located in the 
TR region of the transmitter domain of CheA are characterized by the consensus 
sequences illustrated in Fig 6. 
The G 1 and G2 subdomains (Fig 6) resemble the glycine-rich regions of 
the nucleotide regions of other nucleotide binding domains (Saraste et al., 
1990; Taylor et al., 1992; Schulz 1992; Muller 1993). These subdomains have 
previously been proposed to be the site of Mg-ATP binding and catalysis 
(Parkinson and Kofoid, 1992). Mutations affecting the ability of CheA to 
autophosphorylate have been mapped to this region, suggesting a role for this 
region in ATP hydrolysis (Oosawa et al., 1988; Swanson et al., 1994; Wolfe and 
Stewart, 1993). The G1 region is of particular interest because the first D and 
first G of the DDGAG motif are thought to form a Mg-binding backbone which 
would enable proper positioning of of a Mg-ATP complex (Taylor et al., 1992). 
To date, no detailed studies have been performed to elicit the 
function(s) of the highly conserved residues contained within the putative 
catalytic site of CheA. By analysis of mutants defective in selected amino acids 
within this region of CheA, this study sought to address the following questions 
concerning the function of the conserved subdomains of the CheA transmitter 
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N 
E. C. 370 iidpLtHlvR NslDHGiElp ekRlaaGKns vgnlilsaeh 
s. t. 387 iidpLtHlvR NslDHGiEmp ekRleaGKnv vgnlilsaeh 
E.a. . ......... . . . . . . . .. . . . . . . . . . . . . . ......... 
R.m. 467 ladpLtHliR NavDHGlEtp ekRvaaGKnp egtvrltakh 
R. s. 399 ladpLtHmiR NavDHGlEpa drRlhlGKpp vgliyltaah 
B. s. 399 igdpLvHliR NsiDHGlEap etRlgkGKpe sgkvvlkayh 
L. m. 346 igdpLvHliR NsvDHGaEtv evRrknGKne tatinlkafh 
H.s. 399 isdpLrnHllR NavDHGiEkp avRednGKDar egtitlsaer 
M.x. 367 vrdaLvHllR NsvDHGvEsp dtRgglGKpl ngririrvrv 
Consensus X-OZL-HXXR NZXDHGXE-Z O-R---GK-- -z-x-x-z-J 
Gl 
E.c. 411 gggnicievt DDGaGlnrer ilak.Aasggl . tvse .. nrns 
s.t. 428 gggnicievt DDGaGlnrer ilak.Amsggm .avne .. nrnt 
E.a. . ......... •••..... ek ilak.Aaaggl .avtd .. trns 
R.m. 408 rsqriviela DDGaGinrek vrgk.Aidndl iaada .. nls 
R.s. 440 rsgrvlieik DDGaGinrpr vleiAggkgl vaqda .. qlt 
B.s. 440 sgnhvfieve DDGaGinr.k ilekpler.v itekeattle 
L.m. 387 sgnnvvieia DDGaGinkrk vlek.Aiaknv vtraestkrnt 
H.s. 440 drdhvligvr DDGaGidhdt rnrek.Aiekgv ktreevqdrnp 
M.x. 408 dgdrnlhieve DDGrGidper lrqaAiskrl inavqaaals 
Consensus -Z--X-IOX- D~ZGXOJOJ XX-JA----X -z--o---xz 
F G2 
E.c. 452 ddevarnLiFa pGFSTaeqv tdvSGRGVGMD WkrniqkrnG 
s.t. 469 ddevgmLiFa pGFSTaeqv tdvSGRGVGMD WkrniqernG 
E.a. deevgmliFa pGFSTaeqv tdvSGRGVGMD WkrniqernG 
R.m. 449 deevdnLiFh aGFSTadki sdiSGRGVGMD WkrsiqalG 
R.s. 481 eeeidgLlFrn pGFSTasvv sdlSGRGVGMD WksaieslG 
B.s. 481 dnqiyeLiFa pGFSTadqi sdiSGRGVGMD WknkleslG 
L.m. 428 daeifdLl.d sGFSTadqv sdlSGRGVGlD WrntilkiG 
H. s. 481 dddvedLvFh pGFSTndev tdvSGRGVGrnD Wrdtvtrld 
M.x. 449 ereaieLiFr pGFSTrdqv selSGRGVGrnD WkrkvetlG 
Consensus OOOX--LXF- ZGFSTZOOX ZOXSGRGVGXD WJ--XO-XG 
Fig 6. Amino acid alignment of the N, G1, F, and G2 region of CheA homologs. 
Abbreviations are:Eschericia coli (E.c., Kofoid and Parkinson, 1991), Salmonella 
typhimurium (S.t., Stock et al., 1988), Enterobacter aerogenes ( E.a., Dahl et al., 1989), 
Rhizobium meli/oti (R.m., Greek et al., 1995), Rhodobacter sphaeroides (R.s., Ward et al., 
1995), Bacillus subtilus (B.s., Fuhrer and Ordal, 1991 ), Listeria monocytogenes (L.m., 
Dons, et al., 1994), Halicobacter salinarium (H.s., Rudolph and Oesterhelt, 1995) and 
Myxococcus xanthis (M.x., McCleary and Zusman, 1990). Numbers at left respresent 
amino acid residues. Strictly conserved residues are capitalized. X refers to residues at 
which 70% of the CheA family have a nonpolar amino acid (I,M,L,or V). Z refers to 
residues at which at least 70% of the CheA family have a polar amino acid (A,G,P,S, or 
T). J refers to residues at which at least 70% of the CheA family have a basic amino acid 
(R, K, or H). 0 refers to residues at which at least 70% of the CheA family have an acidic 
or amidic amino acid (D,E,Q, or N). Wild-card positions with less than 70% conservation 
among the kinase family are indicated with dashes. The N, G1, F, and G2 subdomains 
are underlined and strictly conserved residues are in bold. 
N 
CheA consensus X-HXXRNZXDHZ 
Orthodox kinase X-QXXXNXX-NZ 
Gl F 
X-DDGZGXO XF-ZGF 
X-DDGZGXZ XFOPF 
G2 
GJGXGX 
GZGXGX 
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Fig 7. Comparison of the N, G1, F, and G2 consensus sequences between 
CheA and orthodox TR domains X refers to residues at which 70% of the CheA 
family have a nonpolar amino acid {l,M,L,or V). Z refers to residues at which at 
least 70% of the CheA family have a polar amino acid (A,G,P,S, or T). J refers 
to residues at which at least 70% of the CheA family have a basic amino acid 
(R, K, or H). 0 refers to residues at which at least 70% of the CheA family have 
an acidic or amidic amino acid (D,E,Q, or N). Wild-card positions with less than 
70% conservation among the kinase family are indicated with dashes. The 
strictly conserved residues are in bold. 
domain: 
•First, do the subdomains play a role in chemotaxis in vivo? 
•Second, do the subdomains play a role in the ability of CheA to 
autophosphorylate? 
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•Third, are the subdomains involved in formation and maintainance of the 
ternary complex? 
•Fourth, are the subdomains involved in the binding of ATP? 
•Fifth, within a CheA dimer, do the conserved subdomains operate 
independently and in cis, or interdependently and In trans ? 
•Sixth, what can we learn about the structure of the putative catalytic 
region of CheA? 
CHAPTER3 
MATERIALS AND METHODS 
Chemicals and Reagents 
Bacto-tryptone and bacto-yeast extract were obtained from Difeo (Detroit, 
Ml). The restriction enzymes Ndel, BamHI, Munl, Saeli, Xmal, BssHII and M/ul, 
the Wizard™ minpreps kit , the Altered Sites TM in vitro Mutagenesis System, and 
the Wizard™ M13 DNA Purification System were obtained from Promega 
(Madison, WI). BstBI, agarose, glycine, DNA ligase, DNA polymerase, T4 
polynucleotide kinase, proteinase K and 5x forward reaction buffer were 
obtained from Gibco-BRL (Gaithersburg, MD). RNase-A, alkaline phosphatase 
goat anti-rabbit lg, Tris-HCI, isopropyl-B-D-thiogalactopyranoside (IPTG), nitro-
blue tetrazolium (NBT), Na-ampicillin, tetracycline, chloramphenicol, KCI, 
MgCl2, dithiothreitol (OTT), ethylenediaminetetracetic acid (EDTA), acrylamide, 
and Freund's incomplete adjuvant were obtained from Sigma Chemical 
Company (St. Louis, MO). Glacial acetic acid, glycerol, methanol, sodium 
dodecyl sulfate (SOS), chloroform, isopropanol, Na2PO 4 , NaCl, Long Ranger 
gel solution {50% acrylamide solution), and dimethyl sulfoxide (DMSO) were 
obtained from J. T. Baker Inc. (Phillipsburg, NJ). The bromochloro indolyl 
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phosphate (BCIP) bicinchoninic assay (BCA) kit was obtained from Boehringer 
Mannheim (Indianapolis, IN). The lmject Supercarrier™ System for Peptides 
was obtained from Pierce Chemicals (Rockford, IL). The Amplicycle™ 
Sequencing Kit was obtained from Perkin Elmer (Foster City, CA). Biomax 
centrifuge filters were obtained from Millipore (Bedford, MA). [y-32P] ATP and 
[a-32P] ATP were obtained from Amersham (Arlington Heights, IL). 
Bacterial Strains and Alleles 
All strains were isogenic derivatives of E. coli K-12 and are listed in Table 2. 
Alleles CheA8 (Wolfe and Stewart, 1993), cheA, and cheA48HQ (Oosawa et al., 
1988) encode wild-type CheA8 alone, both wild-type CheA8 and wild-type 
CheAL, and both wild-type CheA8 and the mutant protein CheAL 48HQ, 
respectively. This mutant protein cannot autophosphorylate because of a 
His-Gin substitution at position 48. Alleles cheA422GA (herein called cheAG1), 
cheA470GA472GA47 4GA ( cheAG2), cheA422GA470GA472GA4 7 4GA 
( cheAG 1 /G2) and cheA455FY 459FY ( cheA2FY) encode CheA8 and CheAL 
proteins disrupted in G 1 alone, G2 alone, both G 1 and G2 or F alone, 
respectively. Each mutation and unique restriction sites used to track these 
mutations during various in vitro manipulations were generated using standard 
oligonucleotide-directed mutagenesis procedures (Kunkel, 1985). 
Oligonucleotides used for mutagenesis are illustrated in Table 3 and the 
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Table 2. --Bacterial strains used in this study 
Strain Relevant Genotype Source 
AJW531 RP437 cheA470GA472GA474GA recA::cml eda:+- This 
Study 
AJW953 RP437 cheA422GA470GA472GA474GA This 
sr/::Tn 10 eda+ Study 
AJW955 RP437 cheA 422GA recA sr/::Tn 10 eda+ This 
Study 
AJW1071 RP9535 recA::cml This 
BL21(DE3) F- ompT hsdSs (rs- ms-) Ion dcm (').Jmm21 lacl Studier et 
/acUV al. (1990) 
T7 polymerase int) 
BMH71-18 thi supE A(lac-proAB) mutS::Tn 10/F' proA+ £3+ Kunkel 
mutS lac/OZ AM 15 (1985) 
CP366 po/A(Ts) Park and 
Hazelbau 
er(1986) 
DH5cx endA 1 hsdR17 (rK-mK-) supE44 thi-1 recA 1 gyrA Wood-
(NalR) re/A 1 A(lac/ZYA-argF)U169 deoR cock et 
al.(1989) (<P80d/ac A(/acZ)M15) 
JM109 F' traD36 /acP A(lacZ)M15 proA+£3+ I e14- (McrA) Yannisch-
A(/ac-proAB) thi gyrA96 (NalR) endA 1 hsdR17 Perron et 
al. (1985) (rK-mK-) re/A 1 supE44 recA 1 
KO685 ArecA (Sstll-EcoRI) sr/::Tn 10 Hess et 
al. (1987) 
MH6 recA::cml A. Binney 
a 
RP437 thr(Am) 1 /eu86 his-4 metF(Am) 159 eda-50 Parkinson 
rpsL 136 thi-1/acY1 ara-14 mtl-1 xy/-5 tonA31 and Houts 
tsx-78 (1982) 
RP9535 RP437 AcheA 1643 recA:: cm/ eda+ Liu (1990) 
a A. Binney, Purdue University, West Lafayette, Indiana 
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Table 3.--Mutagenesis and sequencing primers 
Primer# M/S8 Allele Sequence 
1 M G1 5'-ACCGACGATGCCGCGGGGCT AA-3' 
2 M G2 5'-GACGTCTCCGCGCGCGCCGTCGCCATGGACGTC-3' 
3 M F 5'-ATGCTGATATACGCACCCGGGTACCCACGGCAG-3' 
4 M CheA709 5'-CCACCCCACATATGCTT AAAC-3' 
5 s CheA 5'-AGAACGCA TT ATCGACCCGC-3' 
6 s CheA 5'-A TTCCAT AACAGCA TTCAGCG-3' 
7 s T7 5'-AACAGCTATGACCATG-3' 
8 s CheA 5'-CCTGGCTTCTCCACGGCAGAGC-3' 
a: M refers to mutagenesis primers and S refers to sequencing primers 
alleles presented in Fig 8. The following oligonucleotides were used: (i) to 
generate the allele cheAG1, 5'-ACCGACGATGCCGCGGGGCTAA-3' which 
substitutes an alanine residue for a glycine at position 422 (Fig 6 and 8) and 
which introduces a unique Saeli restriction site into G1; (ii) to generate the allele 
cheAG2, 5'-GACGTCTCC GCGCGTCGCCATGGACGTC-3' which substitutes 
alanine residues for glycines at positions 470, 472, and 474 (Fig 6 and 8) and 
which introduces a unique BssHII restriction site into G2; and (iii) to generate 
the allele cheA2FY 5'-ATGCTGATATACG CACC CGGGTACCCACGGCAG-3' 
which substitutes tyrosine residues for phenylalanines at positions 455 and 459 
(Fig 6 and 8) and introduces a unique Xmal restriction site in F. Allele 
cheA.1(468-477) (herein called cheA~G2) encodes CheA8 and CheAL proteins 
- - -- ---Allele G1 F G2 
WT DDGAG FAPGF GRGVG 
cheA- G1 DDAAG FAPGF GRGVG 
cheA-G2 DDGAG FAPGF ;RAVA 
cheA- G1/G2 DDAAG FAPGF /P.AVA 
cheA-t:,G2 DDGAG FAPGF 6 
cheA-2FY DDGAG YAPGY GRGVG 
Fig 8. Functional organization of CheA and schematic of cheA 
alleles used in this study. The shaded bars within TR represent the 
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N, G1, F, and G2 blocks of highly conserved amino acids shared by histidine 
kinases of the family of two-component signal transduction systems. Mutant 
amino acids are italicized and underlined. 
33 
deleted for nine amino acids including those that comprise the entire G2 region 
(Fig 6 and 8). 
Media and Growth Conditions 
Cells were grown with aeration in tryptone broth (TB, 1 % (wt/vol) 
Bacto-tryptone, 0.5% (wt/vol) sodium chloride) or in Luria-Bertani broth (LB, TB 
supplemented with 0.5% (wt/vol) Bacto-yeast extract). The optical density at 
61 O nm (OD610) was monitored (Spectronic 20D, Milton Roy Company). 
Bacteria strains containing plasmids to be made single-stranded for 
site-directed mutagenesis were prepared for R408 phage lysis by growth in TYP 
broth (1.6%(wt/vol) Bacto-tryptone, 1.6% (wt/vol) Bacto-yeast extract, 
0.5%(wt/vol) NaCl and 0.25% (wt/vol) K2HPO 4). Competent cells were 
prepared in Yb medium (2% Bacto-tryptone, 0.5% Bacto-yeast extract, and 
0.5% MgSO4, pH 7.6). 
Swarm Assays 
Cells were grown at 32°C to mid-exponential phase (OD610 ~ 0.3) in TB 
supplemented with the requisite antibiotics. Tryptone swarm plates (100 x 15 
mm, Falcon) were constructed by adding 15 ml of 0.20% agar in tryptone broth. 
Antibiotics were not added. A 5 µI aliquot of the culture (106-107 cells) was 
placed on the surface of the swarm plate near its center and the plate incubated 
at 32°C in a humid environment. Swarm plates were handled and measured as 
described previously (Wolfe and Berg, 1989). 
Plasmids used for in vivo swarm plate analyses were derivatives of pAR1 
(Gegner and Dahlquist, 1991 ), which controlled the expression of the cheA 
alleles. 
Plasmid Construction 
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All expression plasmids used to purify proteins were constructed using the 
pET14b (Novagen) his tag purification vector and for the purpose of clarity were 
designated as pDE followed by the allele name Table 4. All expression 
plasmids used for behavioral studies are based on the pAR1 vector (Gegner 
and Dahlquist, 1991) and are designated as pAR1 followed by the allele name 
(Table 4). 
To construct the CheAL purification plasmid pDE.cheA, the CheA 
expression plasmid pAR1 .cheA (Wolfe and Stewart, 1993) was digested with 
Ndel and BamHI. The 2.1-kb fragment containing the cheA gene was ligated 
into an Ndel - BamHI digest of pET14b. To form the CheA8 purification plasmid 
pDE.CheA8 , the CheA8 expression plasmid pAR1 .CheA8 (Wolfe and Stewart, 
1993) was digested with Ndel and BamHI. The 1.8-kb fragment containing the 
CheA8 gene was ligated into an Ndel - BamHI digest of pET14b. The mutant 
allele CheMG2 was generated by digestion of pAR1 .cheA with Aatll. The 27 
bp Aatll-Aatll fragment was discarded and the remainder of the plasmid ligated 
to create an in-frame deletion of 9 amino acids encompassing the G2 region. 
The resulting CheA~G2 expression plasmid was named pAR1 .cheA~G2. To 
construct the purification plasmid pDE.cheA~G2, pAR1 .cheAL1G2 was digested 
35 
with Ndel and BamHI and the 2.09-kb fragment ligated into a pET14b plasmid 
which had also been digested with Ndel and BamHI. pDE.cheA48HQ a 
purification plasmid, encoding the phosphorylation-deficient CheAL 48HQ, was 
generated by removal of a 1 .43-kb Munl - Mlul fragment from the CheAL 48HQ 
expression plasmid pCS30. This fragment was ligated into a 5.22-kb fragment 
of a Munl - Mlul digest of pDE.cheA. pAR1 .cheA48HQ, a cheA48HQ expression 
plasmid, was constructed by removal of a 2.1 kb Ndel - BamHI fragment from 
pDE.cheA48HQ, removing the entire cheA48HQ allele. This fragment was 
ligated into a pAR1 vector derived by digestion of pAR1 .CheA8 with Ndel and 
BamHI. To construct the purification plasmid pDE.cheAG1, a 2.1 kb Ndel -
BamHI digest of the expression plasmid pJN.cheAG1(pJN19) was ligated into 
an Ndel - BamHI digest of pET14b. To construct the expression plasmid 
pJN.cheAG1, a 2.1-kb Ndel - BamHI digest of pJN001.cheAG1 (a pAlter™ 
plasmid containing cheAG1) was ligated into a vector resulting from an Ndel 
-BamHI digest of pAR1 .cheA . To construct pAR1 .cheAG2, a 692 bp BstE II -
BamHI of pDE.cheAG1/G2 was ligated into a vector resulting from a BstBI-
BamHI digest of pAR1.cheA. To construct pDE.cheAG2, a 2.1-kb Ndel-BamHI 
digest of pAR1 .cheAG2 was ligated into an Ndel - BamHI digest of pET14b. 
The expression plasmid pDE.cheAG1/G2, was constructed by removal of a 
2.1-kb Ndel -BamHI fragment of pJN001.cheAG1/G2 (a pAlter based plasmid 
Table 4.--Plasmids used in this study 
Mutation and/a r Allele 
cheA(WT) 
cheA~WT) 
cha4422GA 
cheA470GA/472GN47 4GA 
c~A422 GA/ 470GA/472GA/ifl 4GA 
cha4481-0 
cheAA(468-476) 
Expression 
Aasmids 
pAR1.cheA 
pAR1.cheAs 
pAR1 .cheAG 1 
pAR1 .cheAG2 
pAR1 .cheAG1/G2 
pAR1 .cheA4BHQ 
pAR1 .cheAAG2 
Plasmids to Express 
his-tagged Proteins 
pDE.cheA 
pDE.cheAs 
pDE.cheAG1 
pDE.cheAG2 
pDE.cheAG1iG2 
pDE.cheA48HQ 
pDE.cheAAG2 
containing the cheAG1/G2 mutation). This fragment was ligated into a vector 
resulting from an Ndel - BamHI digest of pAR1 .cheA. To construct 
pDE.cheAG1/G2, a 2.1-kb Ndel-BamHI digest of pJN.cheAG1/G2 was ligated 
into an Ndel-BamHI digest of pET14b. To construct pAR1 .cheAG2, a 692 bp 
BstEII-BamHI digest of pDE.cheAG1/G2 was ligated into a vector resulting 
from a BstEII-BamHI digest of pAR1 .cheA. This fragment was ligated into 
36 
a vector resulting from an Ndel - BamHI digest of pAR1 .cheA. To construct 
pDE1.cheAG1/G2, a 2.1-kb Ndel - BamHI digest of pJN.cheAG1/G2 was ligated 
into an Ndel - BamHI digest of pET14b. To construct pAR1 .cheAG2, a 692 bp 
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BstBI - BamHI digest of pDE.cheAG1/G2 was ligated into a vector resulting from 
a BstE II - BamH I digest of pAR1 .cheA. 
Competence Procedure 
To make cells competent for transformation, a single freshly isolated colony 
was inoculated into 125 mis of Yb medium and aerated at 37°C until the culture 
reached an optical density (OD550) of 0.3. This culture was diluted 1 :20 in 
pre-warmed Yb medium and grown at 37°C with aeration until the culture 
reached an OD550 of 0.48, whereupon it was immediately placed on ice for 5 
min and then pelleted by centrifugation at 3000 x g in a Beckman tabletop The 
cell pellet was resuspended in 40 mis cold (4°C) Tbf1 buffer (30 mM KOAc (pH 
5.8), 100 mM KCI, 10 mM CaCl2, 50 mM MnCl2 , 15% glycerol) for 5 min and 
pelleted by centrifugation at 3000 x g. The supernatant was decanted and the 
pellet resuspended in 4 mis of Tbf2 (1 O mM MOPS (pH 6.5), 75 mM CaCl2, 1 O 
mM KCI, 15% glycerol) and left at 4°C for 15 min before use. Cells were divided 
into 250 µI aliquots and stored frozen at -70°C until needed (approx. 0.5 x 109 
cells/ml). 
Site-Directed Mutagenesis 
Mutagenesis of the putative catalytic domain was performed using the 
Altered Sites™ in vitro Mutagenesis System (Promega). A BamHI digest of 
pAR1 .cheA which included both cheA and flanking sequences was ligated into 
a calf alkaline phosphatase (CIP, Gibco-BRL)-treated BamHI digest of the 
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mutagenesis vector pAlter™. The ligation reaction was transformed into DH5a, 
plated onto LB plates containing tetracycline (15 µg/ml), and incubated at 37°C 
for 16 hrs. Tetracycline resistant colonies were inoculated into 5 mis of LB 
containing tetracycline (15 µg/ml) and allowed to grow to saturation overnight at 
37°C. The overnight cultures were pelleted by centrifugation and the plasmids 
isolated by use of the Wizard™ miniprep DNA purification system. The insert 
was mapped by restriction analysis for a 5' - 3' orientation relative to the T7 
promotor present in pAlter™. A plasmid containing the proper insert in the 
correct orientation was selected and named pJN001. 
Single-stranded DNA used as a template in all site-directed mutageneses 
was obtained by transforming pJN001 into strain JM109. One freshly isolated 
colony was inoculated into 2 mis of TYP broth and incubated overnight at 37°C 
with aeration. 100 µI of the overnight culture was inoculated into 5 mis of TYP 
broth containing 15 µg/ml of tetracycline and aerated at 37°C. After 30 min, the 
culture was infected with the helper phage R408 at a multiplicity of infection 
(MOI) of approximately 10, shaken for an additional 6 hrs, and the culture was 
then centrifuged at 3000 x g to remove whole cells and debris. Single-stranded 
DNA was isolated from the supernatant by use of the Wizard™ M13 DNA 
purification system. 
Mutagenesis of pJN001 was performed according to the guidelines 
outlined by Promega . Phosphorylated oligonucleotides ( one designed to 
introduce a mutation into CheA and one designed to repair the ~-lactamase 
gene in pAlter) were annealed to the single-stranded pJN001 template (0.05 
pmol pJN001, 0.25 pmol ampicillin repair oligonucleotide, 1.25 pmol cheA 
mutagenic oligonucleotide, 2 µI 1 OX annealing buffer, final volume 20 µI) by 
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incubation at 70°C for 5 min and slow cooling to room temperature for 30 min. 
The annealing mix was allowed to extend and repair (3 µI 1 OX synthesis buffer, 
1 O U T 4 DNA polymerase, 2 U T 4 DNA ligase, final volume 30 µI) at 37°C for 90 
min. Following the extension reaction, the entire mix was transformed into 
competent BMH71-18 mutS cells. The BMH71-18 mutS containing the 
mutagenesis mix was inoculated into 4 mis of LB containing 100 µg/ml of 
ampicillin and incubated overnight at 37°C with aeration. The overnight culture 
was pelleted by centrifugation at 3000 x g and plasmids isolated by the 
miniprep system described previously. The plasmid preparation then was 
transformed into competent DH5a cells and plated on LB agar containing 
ampicillin (100 µg/ml) and tetracycline (15 µg/ml). Ampicillin resistant colonies 
were inoculated into 5 mis of LB broth containing ampicillin (100 µg/ml) and 
grown overnight at 37°C with aeration. Plasmids isolated from these overnight 
cultures were mapped for the presence of the unique restriction sites introduced 
as markers for each mutation. All mutations generated were confirmed by 
sequence analysis. 
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Homologous Recombination 
Alleles cheAG1, cheAG2 and cheAG1/G2 were introduced into the 
chromosome by means of homologous recombination in the po/A {Ts) strain 
CP366 (Park and Hazelbauer, 1986). Briefly, plasmids containing the mutant 
alleles were transformed into CP366, plated onto LB plates supplemented with 
ampicillin (100 µg/ml), and incubated overnight at 42°C. Ampicillin-resistant co-
integrants were selected, inoculated into LB without antibiotics and passaged 
repeatedly (1 0 X) at 37°C. A sample of the final passaged culture was serially 
diluted such that about 200 colonies were plated onto LB plates without 
antibiotic and grown overnight at 37°C. Ampicillin-sensitive recombinants were 
identified by replica-plating onto LB plates either containing ampicillin (100 
µg/ml) or not. Chromosomal preparations were prepared from 6 ampicillin-
sensitive colonies and the existence of each mutation verified by restriction 
analysis of polymerase chain reaction (PCR) products using primers designed 
to amplify the entire G1-F-G2 region. Each mutation was marked by a silent 
mutation that introduced a unique restriction site that flanked the mutation. 
P1 transduction (Silhavy et al., 1984) was used to transfer each mutant 
allele out of its PolA(Ts) host into the PolA+RecA+Che+ recipient strain RP437 
and to make the resultant transductants recA by using either strain MHS- or 
KO685 as the donor. The recipient strain RP437 carries an eda- phenotype. 
Recombinants of the chemotaxis operon (42.5 min) of RP437 can be selected 
by virtue of repair of the eda locus (41.5 min). Transductants that recombined 
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the mutated cheA alleles into RP437 were selected by their eda+ phenotype. 
The eda+ recombinants were screened for nonchemotactic behavior. Those 
that proved nonchemotactic were then tested for their ability to perform wild-type 
chemotactic behavior when transformed (Silhavy et al., 1984) with pAR1 .cheA, 
a plasmid that encodes both CheA8 and CheAL. Chromosomal preparations 
were prepared of each putative recombinant and the entire G 1-F-G2 region 
amplified by PCR. The presence of the mutation was verified by restriction 
analysis and sequencing of the amplified product. The mutant alleles are 
presented in Fig 8. 
Purification of His-tagged proteins 
To purify CheAL, the 2.1-kb Ndel-BamHI fragment from pAR1 .cheA 
(Wolfe et al., 1994) was subcloned into pET14b (Novagen Inc., Madison, WI), 
generating the plasmid pDE1. This plasmid permits expression, by means of 
the bacteriophage T7<!>1 O promoter, of a 6XHis sequence fused to the 
amino-terminus of CheAL. To purify mutant CheAL proteins, the 5.9-kb Stul-M/ul 
restriction fragment of pDE1 was ligated to 1.2-kb Stul-Mlul fragments from each 
of the respective pAR1 derivatives. To purify CheA8 , the 1.8-kb Ndel-BamHI 
fragment from pAR 1.CheA8 (Wolfe et al., 1994) was subcloned into pET14b 
(Novagen Inc., Madison, WI). To purify the TMC fragment of wild-type CheA, an 
Ndel site was engineered at cheA nucleotides 706 - 711 and the resultant 
1 .4-kb Ndel-BamHI fragment was subcloned into pET14b. Each protein used in 
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this study was purified by transforming the plasmid which expressed the 
appropriate 6X his-CheA variant fusion protein under control of the T7 promoter, 
into BL21 (DE3), a strain which expresses T7 RNA polymerase under the control 
of lacP {Studier et al., 1991 ). Cells of the resultant transformant were grown 
overnight in 5 ml of LB in the presence of ampicillin (100 mg/ml). The overnight 
culture was diluted 1: 100 in LB containing ampicillin (200 mg/ml) and grown to 
an OD610 of~ 0.4 at 30°C before adding 0.1 mM IPTG and more ampicillin (200 
µg/ml). After a 3 hr incubation under inducing conditions, the cells were 
harvested by centrifugation at 3,000 x g for 20 min at 4°C. Purification of the 
fusion protein and cleavage of the 6XHis sequence were performed according 
to the manufacturer's instructions (Novagen [Hoffman and Roeder, 1991 ]), 
except that the thrombin:protein ratio was 1: 1000. Protein concentrations were 
determined by the BCA assay. 
To purify the 30-kDa fragment that results from spontaneous 
degradation of the mutant protein CheAL G 1, we filtered the mixed degradative 
pool of that protein through a SOK nominal molecular weight limit (NMWL) 
Biomax filter (Millipore). Because the protein was fused to an amino-terminal 
6X his sequence, we reabsorbed the resultant Biomax filtrate over His-bind 
resin (Novagen), eluted those fragments that bound, and equilibrated them in 
TKMD buffer (50 mM Tris-HCI, 50 mM KCI, 5 mM MgC12, 0.5 mM dithiothreitol 
[pH 7.51). 
To purify spontaneous degradative fragments of CheAL G1 that include the 
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TMC domains, we first absorbed a mixed degradative pool of CheAL G 1 
fragments to His-bind resin to remove any fragments containing an 
amino-terminal 6XHis sequence. We then filtered the unbound fragments 
sequentially through SOK NMWL and 30K NMWL filters. This process resulted 
in a mixed population of fragments ranging in size from 30- to 50-kOa,size 
range which includes TMC-containing fragments. 
In Vitro Phosphorylation of Proteins. SOS-PAGE. Autoradiography and 
lmmunoblot Analysis 
Phosphorylation reactions contained the indicated proteins in TKMO buffer 
and 50 µM [y-32P]ATP (~ 2500 cpm pmol"1) at 25°C for the times indicated. 
Reactions were terminated by the addition of 3X SOS-PAGE sample buffer. 
Samples were subjected to SOS-PAGE (10% polyacrylamide gels) at 10 to 
15°C in a Hoefer (San Francisco, Ca) SE600 gel apparatus under the 
conditions of Laemmli (1971 ). Following electrophoresis, the gels were 
incubated for 2X at 25°C for 1 hr in drying buffer (45% methanol, 7.0% glacial 
acetic acid, 10% glycerol, 0.5% dimethyl sulfoxide), dried for 2 hrs and 
visualized by autoradiography. 
Sequencing 
Mutations in the catalytic domain were confirmed by direct cycle 
sequencing using the Amplicycle sequencing kit (Perkin-Elmer). Templates for 
sequencing were derived either from plasmids containing mutant alleles in the 
catalytic domain of cheA or chromosome preparations from E. coli cells which 
had cheA catalytic site mutations introduced into the chromosome by 
homologous recombination. For each allele sequenced, 6 µI of the template 
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mix (4 µI of cycling mix, 1 µI of [y2P]-ATP, 15 µI of template (100-150 µg/ml), and 
1 O µI of sterile H20 ) was added to 0.25 ml microfuge tubes containing 2 µI each 
of the G, A, T, and C termination nucleotides. 7-deaza-GTP was added to inhibit 
compressions. 
The sequencing mix was subjected to 30 cycles in an an Omn-E, 
(Hybaid) thermocycler under the following conditions. Pre-warm cycle (5 min, 
95°C), melting cycle (1 min, 95°C), annealing cycle (1 min, 62°C), extension 
cycle (1 min, 72°C). 
Primer End-Labeling 
Primers used for sequencing were end-labeled according to the method 
of Donis-Keller et al. (1977). A reaction mix was prepared consisting of 5 pmol 
primer, 5 µI of 5X forward reaction buffer, 1 µI (10 U) of T4 polynucleotide 
kinase, 2.5 µI of [ y-32P]ATP (10 µCi/ul, 3000 Ci/mmol), and sterile H20 to a total 
volume of 25 µI. The contents were mixed thoroughly and incubated at 37°C for 
10 min. The reaction was stopped by the addition of 4 µI of 500 mM EDT A. 
Alternatively, a reaction mix was prepared consisting of 5 µI [y-32P]ATP 
(10 µCi/ul, 3000Ci/mmol), 1 µI of 10x reaction buffer, 1 µI of 100 mM DTT, 3 µI of 
T 4 polynucleotide kinase and 0.8 µI of 20 µM primer. The contents were mixed 
thoroughly and incubated at 37°C for 10 min. The reaction was terminated by 
incubation of the mixture at 94°C for 5 min. 
Genomic DNA Preparation 
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To confirm chromosomal mutations in the putative catalytic domain of 
CheA, genomic DNA was prepared as described (Ellefson and Wolfe 1997). 
100 mis of E. coli cells were grown overnight in LB. The overnight culture was 
pelleted by centrifugation and washed once in 1 X SET buffer (20 mM Tris pH 
7.5, 75 mM NaCl, 25 mM EDTA). The washed pellet was resuspended in 5 ml 
of SET buffer and transfered to a 15 ml polypropylene tube. Lysozyme was 
added to 1 mg/ml and the solution incubated at 37°C for 30 min. RNase A was 
added to a concentration of 0.4 mg/ml and the solution incubated for an 
additional 30 min at 37°C. Following the 60 minute incubation, 0.1 volumes of 
10% SOS and 1 mg/ml of proteinase K was added and the entire solution 
mixed and allowed to incubate in a 56°C water bath. After 2 hrs, 0.33 volumes 
of 6M NaCl was added to the solution and mixed gently. One volume of 
chloroform was then added and the entire solution rotated for 1 hr at 23°C. The 
solution was then centrifuged for 1 O min at 3000 X g to separate the organic 
phase from the aqueous phase. The aqueous phase was transferred to a fresh 
15 ml polypropylene tube. One volume of isopropanol was added and the 
solution was inverted frequently to precipitate the chromosomal DNA. The DNA 
was transferred with a glass pipet to a 1 .5 ml microfuge tube, rinsed with 70% 
EtOH, and pelleted by centrifugation. The supernatant was decanted from the 
pellet which was air dried to remove extraneous EtOH. The dried pellet was 
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resuspended in cold H
2
0 and stored at -20°C. 
Western Analysis 
lmmunoblot analyses, using affinity-purified rabbit anti-CheA antibodies, 
were performed by standard procedures (Harlow and Lane, 1988). 40 µg or 5 
µg of a total protein lysate were separated by SOS-PAGE analysis. The 
proteins were transferred to nitrocellulose (0.2 µm, Schleicher and Schull) in a 
Trans-Blot cell (Bio-Rad, Hercules) overnight at 4°C and 40V. The transfer 
buffer contained the following: Tris 3 g/I, Glycine 14.4 g/1, Methanol 200 ml/I. 
Unreacted sites on the nitocellulose blot were blocked by immersion for 1 hr in 
100 mis of blotto (Tris-buffered saline/ 0.1% Tween-20 (TBS-T), 5% nonfat dry 
milk). The blots were rinsed twice and then washed three times each for 15 
min in TBS-T on a rotating platform. Pre-absorbed anti-CheA antiserum or 
anti-CheAL serum were diluted to a concentration of 1 : 10,000 in TBS-T and 
incubated with the appropriate blot for 1 hr at room temperature. Following 
incubation with primary antibody, the blots were rinsed and washed as 
described above. The blots were incubated for 1 hr at 23°C with 
alkaline-phosphatase conjugated anti-rabbit lgG (Sigma) diluted in TBS-T to a 
concentration of 1 : 15,000. The blots were washed with TBS-T once for 15 
min and three times for 5 min to remove unbound antibody. Following the 
wash, the blots were rinsed twice with an equilibrating buffer consisting of 150 
mM NaCl, 50 mM Tris-HCI, [pH 7.5]. Reactive bands were visualized by adding 
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66 ml of nitro blue tetrazolium (NBT, 50 mg/ml in 70% dimethylformamide, 
Sigma) and 33 ml of bromochloro indolyl phosphate (BCIP, 50 mg/ml in 100% 
dimethylformamide, Sigma) into 1 O ml of alkaline phosphatase buffer (100 mM 
Tris-HCI pH9.5, 5 mM MgCl2) and incubating the blot until color development 
occurs. The reaction was stopped by the addition of 5 mM EDT A. Blots were 
washed in distilled H20 and dried between Whatman filters. 
Generation of CheAL-Specific and CheA antisera 
High-titer antiserum recognizing only the long form of CheA was 
generated in rabbits by immunization with a conjugate of a CheAL-specific 
peptide and bovine serum albumin (BSA) carrier. A CheAL-specific peptide, 
IKGGAGTFGFS, corresponding to amino acids 50-60 in CheAL was coupled to 
BSA and keyhole limpet hemocyanin (KLH) by use of the lmject Supercarrier™ 
EDC system for Peptides (Pierce). The peptide/KLH conjugate was used as an 
irrelevant carrier to screen the resulting antiserum for peptide reactive antibody 
by ELISA. Each carrier was reconstituted into 200 µI of deionized water and 
incubated with 2 mg of peptide dissolved into 500 µI of conjugation buffer (pH 
4.7). The peptide/carrier mix was added to a vial containing 
1-ethyl-3-(3-dimethylaminopropyl carbodiimide) hydrochloride (EDC). The 
peptide/carrier/EDC mix was allowed to incubate at 23°C for 2 hrs. The 
peptide/carrier conjugates were purified over a cross-linked dextran sulfate 
column pre-equilibrated with purification buffer (83 mM Na2PO 4 
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pH 7.2, 900 mM NaCl). 0.5 ml aliquots of purification buffer were absorbed over 
the column and collected in separate tubes for analysis. The hapten-carrier 
conjugate, eluted in fractions 4 - 6. These fractions were pooled and the 
coupling efficiency calculated by comparing of peptide (by absorbance at 
280nm) before conjugation with the peptide concentration in the eluate arising 
from the coupling column. The coupling efficiency of the peptide to both the 
BSA and KLH carrier conjugates was estimated at approximately 78% (approx. 
1 0 peptides/molecule BSA). The BSA/peptide conjugate was dialyzed against 
phosphate buffered saline (PBS), quantitated by BCA analysis (a protein 
determination kit from Pierce), and 100 µg resuspended in 1 ml of Fruend's 
incomplete adjuvant. The mixture was shaken for 1 min in a model 5100 
mixer/shaker (Spex) and drawn into a 3 ml disposable syringe. Pre-immune 
serum was collected from a female New Zealand White rabbit (approx. 5 kg). 
The rabbit was injected subcutaneously at 5 separate sites in the dorsal-lumbar 
region. After 4 weeks, the rabbit was boosted with 50 µg of the peptide/ BSA 
conjugate in a manner similar to that outlined above. Two weeks after 
boosting, 35 mis of blood was taken by ear puncture and the serum collected by 
allowing the blood to coagulate overnight at 4°C. Serum reactivity against the 
peptide was analyzed by indirect detection of peptide titer by enzyme-linked 
immunosorbant assay (ELISA) using the peptide-KLH conjugate as the antigen 
according to the method of Van Regenmortel (1988) . Briefly, 50 µg/ml of 
peptide/KLH conjugate was dialyzed against carbonate buffer (15mM Na2CO3 , 
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35 mM NaHCO
3
, pH 9.6, 4°C). Each well of a a 96-well plate was absorbed 
overnight at 4°C with 100 µI of the dialyzed peptide/KLH conjugate mixture. 
The plates were washed three times with PBS/0.1 % tween-20 and the 
unreacted sites blocked by incubating the plate at 37°C for 1 hr with a 100 µI of 
10 mg/ml of KLH in PBS/0.1 % tween-20. The unreacted KLH was removed by 
washing 3 times in PBS/0.1 % tween-20. Peptide-reactive antiserum was 
quantitated by aliquoting 100 µI/well of 2-fold serial dilutions of serum ranging 
from 1:100 to 1:10,000 and incubating the plate at 37°C for 2 hr. The plate was 
washed 3 times in PBS/tween-20 and incubated with alkaline-phosphatase 
conjugated goat anti-rabbit lg (Sigma, 1:10,000) for 2 hrs at 37°C. The wells 
were washed 3 times with PBS/tween-20 and incubated for 2 hr at 37°C in 
substrate (3 mM p-nitrophenyl phosphate, 0.05 M Na2CO3, 0.5 mM MgCl2 ). 
The absorbance was read at 405 nm with a spectrophotometer. 
Generation of antiserum against both the long and short forms of CheA 
was performed in a manner similar to the one outlined above except his-tagged 
CheA protein was used as the primary immunogen instead of a 
peptide-conjugate mixture. 
ATP Binding Assay 
The binding of ATP to wild-type and mutant CheA was performed 
according to the method of Ninfa et. al (1993). Each wild-type and mutant CheA 
protein was diluted to 5 µM in TKMG buffer (50 mM Tris-HCI pH 8.0, 60 mM 
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KCI, 5.0 mM MgCl
2
, and 5.0% glycerol), and incubated with [a-32P]ATP. A 40 
µI aliquot of each protein was dispensed into separate wells of a 96 well 
microtiter plate and exposed to UV light (254 nm) for 3 min with a UV 
Stratalinker model 1800 (Stratagene, LaJolla, California). The reactions were 
stopped by the addition of 3X sample buffer and subjected to SOS-PAGE and 
autoradiography. 
Quantitation of ADP binding was performed as described (Thomas et al. 
1992; Hiratsuka 1982). Progressively higher concentrations of the fluorescent 
ADP analog TNP-ADP were titrated into a 1 O µM concentration of wild-type or 
mutant CheA. By itself, TNP-ADP has a low level of fluorescence, but there is a 
significant increase in fluorescence when the analog is bound to a kinase. This 
increase was quantified by measurement of the absorption spectra in an 
Applied Photophysics SX19MV spectrofluorimeter (model SK.1 E). Data were 
plotted as fluorescent intensity versus TNP-ADP concentration. These titration 
profiles were fitted with a least squares program to calculate the binding affinity 
of the analog. 
CHAPTER4 
RESULTS 
In Vivo Analysis of CheA Putative catalytic domain Mutants 
Rationale for design of catalytic mutants: Parkinson and Kofoid 
(1992) proposed, on the basis of sequence homology to the catalytic sites of 
eukaryotic serine/threonine kinases, that the transmitter domain of CheA is the 
site of ATP catalysis. To test this hypothesis, ideally one would first derive 
structural information from x-ray crystallography or multidimensional NMR 
analyses and then obtain information via functional analysis of selected 
mutants. Unfortunately, there have been no successful structural studies of the 
putative catalytic domain of CheA or that of any other two-component histidine 
kinase. Thus, I have chosen to use mutagenesis to obtain functional and 
structural information concerning the putative catalytic domain of CheA. To 
design a mutagenic strategy, I first compared the sequence of the catalytic 
domains of serine/threonine kinases and with that of several histidine kinases 
(Saraste et al. 1990, Schultz 1992, Taylor et al. 1992, Ninfa et al. 1993, Yang 
and Inouye 1993). I chose three highly conserved regions (G1, F, and G2) for 
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mutant analysis of catalytic function. Since G 1 and G2 are glycine-rich regions, 
I decided to generate a series of conservative glycine to alanine changes 
because researchers have traditionally used alanine substitutions to facilitate 
functional analysis of the catalytic regions of other kinases (Atkinson and Ninfa; 
1993, Ninfa et al., 1993) and because a variety of structure averaging 
algorithms predicted that G to A substitutions would cause no obvious 
alterations in the secondary structure of those regions. Thus, I expected that 
such mutations had a good chance of preserving the general architecture of the 
mutated protein. In the F region, which is phenylalanine-rich, I introduced F to 
Y and F to W mutations. Because tyrosine (Y) differs from phenylalanine (F) 
only in the presence of a reactive hydroxyl group on the aromatic ring, I 
expected F to Y to be the most conservative of the two substitutions. In contrast, 
I expected that a tryptophan (W) substitution might cause a more severe 
phenotype since it contains an additional ring that may cause steric problems 
(Sharp et al. 1995, Sharp, et al., 1995). 
Using these mutations, I sought to address the following questions 
concerning the function of the conserved subdomains within the transmitter 
domain of CheA: 
•First, do these subdomains play a role in chemotaxis in vivo? 
•Second, do these subdomains play a role in the ability of CheA to 
autophosphorylate? 
•Third, are the subdomains involved in formation and maintainance of the 
ternary complex? 
•Fourth, are the subdomains involved in the binding of ATP? 
• Fifth, within a CheA dimer, do the conserved subdomains operate 
independently and in cis, or interdependently and in trans ? 
•Sixth, can we make predictions concerning the structure of the putative 
catalytic region of CheA? 
Mutant Alleles Defective in the Putative Catalytic Domain do not Support 
Chemotaxis/n Vivo 
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A deletion of cheA eliminates the ability of the cell to perform chemotaxis 
(Liu and Parkinson, 1989). Since CheA is a histidine kinase, mutations 
designed to disrupt the binding of ATP should affect the ability of CheA to 
autophosphorylate. Such mutations would disrupt the phospho-relay and, thus, 
affect chemotaxis. Thus, I inoculated cells carrying either the wild-type allele 
cheA (strain RP437) or the mutant allele cheAG1 (strain AJW955), cheAG2 
(strain AJW531),cheAG1/G2 (strain AJW 953) or cheAt1G2 (strain AJW415) at 
the center of tryptone swarm plates and, after 6 hr of incubation, compared the 
displacements of the outermost edges of their resultant swarms (Fig 9). Wild-
type cells (Fig 9A) formed two rapidly migrating concentric bands (0.72 cm h,1 
for the outermost band), indicating that such cells are chemotactic for both L-
serine and L-aspartate (Adler 1966). In contrast, cells of each mutant strain 
formed dense irregular swarms that migrated at a rate (0.02 cm hr·1) 
characteristic of nonchemotactic cells that cannot tumble, e.g., the t1cheA strain 
AJW1071 (Fig 9B). 
To determine whether increased expression of the mutant proteins could 
confer chemotactic ability, I transformed the mutant alleles cheAG1, cheAG2, 
WT 
A 
11cheA 
B 
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Fig 9. Pho tog raphs of representative swarms demonstrating that 
wild-type cells (A) form two concentric rings whereas cells deleted for 
cheA (B) do not. Cells were inoculated near the center of replicate 
trypto ne swarm plates containing 0.2% agar, and the plates were 
incubated at 32°C for 6 hr. Experiment is representative of repetitive 
experiments ( >1 0). 
cheAG1/G2, cheA G2, or cheA2FY or cheA2FW (each carried by the IPTG-
inducable vector pAR 1) into the !lcheA strain AJW1071 . For positive and 
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negative controls, I also transformed this !lcheA strain with the alleles cheA 
and CheA8 (also carried by the vector pAR1). I inoculated cells of the resultant 
transformants at the center of tryptone swarm plates containing 25 µM I PTG 
and, after 6 hrs of incubation, compared the displacement of outermost edges of 
the swarms. As shown in Fig 10, only cells that expressed both CheAL and 
CheA8 formed two rapidly migrating concentric bands (Panel A). Those that 
expressed variants of CheA mutated in G1 (Panel 8), G2 (Panel C), G1/G2 
(Panel D), or F (Panel E) formed dense nonchemotactic swarms 
indistinguishable from those produced by the cells of AJW1071 alone (Fig 98). 
The Inability to Perform Chemotaxis is not due to a Metabolic Defect 
The inability of mutants of the putative catalytic domain of CheA to perform 
chemotaxis could be due solely to reduced catalytic activity. Alternatively, it 
could be due to reduced ability to metabolize serine. A reduction in the ability 
to metabolize an amino acid such as serine would manifest itself as a reduced 
growth rate. To distinguish between these possibilities, I transformed the !lcheA 
strain AJW1071with pAR1 derivatives that carried the alleles cheA, cheA8, 
cheAG1, cheAG2 or cheAG1/G2 (each carried by the IPTG-inducible vector 
pAR1 ). I then measured the growth rate of each transformant in TB at 32°C 
either in the absence of IPTG or in the presence of 
50 µM IPTG. All transformants grew at about the same rate, regardless of IPTG 
A cheA 8 cheAG1 
C cheAG1 I G2 D cheAG2 
E cheA2FY F cheA2FW 
Fig 10. Photographs of representative swarm patterns demonstrating 
that increased expression of plasmid-borne cheA mutants does not restore 
chemotaxis to cells deleted for cheA: cells deleted for cheA and 
transformed with either pAR1 .cheA (A}, pAR1 .cheAG1 (B), pAR1 .cheAG2 
(C), pAR1 .cheAG1/G2 (D), pAR1 .cheA2FY (E), or pAR1 .cheA2FW. All 
cells were inoculated in duplicate onto replicate (x 5)TB swarm plates 
supplemented with 25 mM IPTG to induce expression of the plasmid-borne 
alleles. 
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Fig 11. Growth curves demonstrating that cells deleted for cheA ( v) or 
deleted for cheA and transformed with pAR 1 derivatives that carry the 
alleles cheA ( ■), cheAG1 ('~ ), cheAG2 ( e), or cheAG1/G2 ( □)grow at 
about the same rate. Cells were inoculated into TB supplemented with no 
IPTG (A) or 50 µM IPTG (B) and incubated at 32oC. This experiment was 
performed twice. 
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induction (Fig 11). 
CheAs. but not CheA6 48HQ Restores of Chemotactic Ability to Kinase-Detident 
CheAL Mutants 
CheA8 lacks the N-terminal 97 amino acids including the site of 
phosphorylation (48H). However, it still possesses a functional catalytic 
domain. In contrast, variants of the putative catalytic domain of CheAL possess 
the site of phosphorylation, but presumably lack kinase activity. CheA functions 
as a dimer (Surette et al., 1996). Furthermore, the expression of CheA8 
restores chemotaxis to cells that express the kinase-deficient mutant CheAL-
470GK, presumably by forming a heterodimer (Swanson et al., 1993; Wolfe and 
Stewart 1993). Therefore, to test whether the non-phosphorylatable variant 
CheA8 can also restore chemotactic ability to mutant cells that express other 
CheA variants defective in the glycine-rich regions, I transformed the allele 
cheA8 (carried by the vector pAR1) into cells carrying chromosomal copies of 
the mutant alleles cheAG1, cheAG2 or cheAG1/G2 (strains AJW955, AJW531 or 
AJW953, respectively). Cells of the resultant transformants were inoculated at 
the center of tryptone swarm plates containing 25 µM IPTG and, after 6 hrs of 
incubation, the displacements of their swarm fronts were compared (Fig 12). 
Transformants of strains AJW955 and AJW531 (alleles cheAG1 and cheAG2, 
respectively) formed two concentric bands (Panels D and E) that resembled 
those of the wild-type strain RP437 (Panel A). The outermost bands, formed by 
these transformants in response to L-serine, migrated about 0.28 cm h 1 and 
0.33 cm h-1, respectively. In comparison, pAR1 .cheA transformants of the 
ilcheA strain AJW1071 formed an outermost band that migrated at a rate of 
0.49 cm h-1 (Panel C). In contrast, transformants of strain AJW953 (allele 
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cheAG 1 /G2) formed dense non-chemotactic swarms (Panel F) that migrated as 
slowly (0.02 cm h-1) as cells of the ilcheA strain AJW 1071 (Panel B), even when 
the concentration of IPTG was increased to as much as 100 µM. Expression of 
CheA8 restores chemotactic ability to cells that express CheA proteins mutated 
in either the G1 or G2 regions but not both. 
Likely, this occurs because CheA8 forms a functional heterodimer with each 
of the catalytic mutants. The non-phosphorylatable mutant CheAL 48HQ was 
chosen as a control because, like CheA8 , it possesses an intact putative 
catalytic domain and no site of phosphorylation. Since the putative catalytic 
domains of CheA8 and CheAL 48HQ, are identical, the expression of 
CheAL 48HQ should also restore chemotaxis to a CheAL protein mutated in the 
conserved G 1 and G2 subdomains. I transformed the plasmid pAR 1 . cheA48HQ 
into cells carrying the mutant alleles cheAG1 (strain AJW955) or cheAG2 
(AJW531 ), inoculated cells of the resultant transformants at the center of 
tryptone swarm plates containing 25 µM IPTG and, after 6 hrs of incubation, 
compared the displacement of their swarms. Transformants of both strains 
formed dense, non-chemotactic swarms indistinquishable from those produced 
A 
D 
cheA 
cheAG1 
+ 
cheA5 
B 
E 
LlCheA 
cheAG2 
+ 
cheA5 
C 
LlCheA 
+ 
cheA 
cheAG1/ G2 
+ 
cheA5 
F 
Fig 12. Photographs of representative swarm patterns demonstrating that 
CheAs restores chemotaxis to cells that express the kinase-deficient mutants 
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CheALG1 or CheALG2 but not CheALG1/G2. Wild-type cells (A, strain RP437), 
cells deleted for cheA (B, strain AJW1071 ), cells deleted for cheA and transformed 
with pAR1 .cheA (C),cells carrying the allele cheAG1 and transformed with 
pAR1 .cheAs (D), cells carrying the allele cheAG2 and transformed with 
pAR1 .cheAs (E), and cells carrying the allele cheAG1/G2 and transformed with 
pAR1 .cheAs (F). Cells were inoculated at the center of tryptone swarm plates 
containing 0.2% agar, and the plates incubated at 32°C for 6 hr (replicate, x5). 
Expression of CheA variants was induced with 25 µM IPTG. 
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by the parent cells or those of the !!,.cheA strain, AJW1071 (Fig 128). Thus, in 
contrast to that of CheA8, expression of CheAL 48HQ does not restore 
chemotactic ability to cells that express CheA proteins defective in either the G 1 
or G2 regions. 
Similarly, cells that carried the mutant allele cheAG1 transformed with the 
allele cheAG2 (carried by the IPTG-inducible vector pAR1) and cells that 
carried the mutant allele cheAG2 transformed with the allele cheAG1 (also 
carried by pAR1) formed only non-chemotactic swarms that migrated slowly 
regardless of IPTG concentration. Thus, CheAL G1 and CheAL G2 variants 
cannot complement each other in vivo. 
Dominance of Various CheA Catalytic Mutants 
To determine the effect exerted by the putative catalytic mutants upon the 
ability of wild-type CheA to perform its proper function, I explored the possibility 
that the phenotypes resulting from these mutations could be explained by an 
acquired ability of the mutants to exert a dominant negative effect. I transformed 
wild-type cells with the following alleles: cheA, cheAG1, cheAG2, cheAG1/G2, 
or cheAAG2 (each carried by the IPTG-inducible vector pAR1 ). Each 
transformant was inoculated in duplicate onto the center of replicate swarm 
plates containing 25 µM IPTG and their migration rate followed over 6 hrs (Fig 
13). Wild-type cells transformed with cheA (panel A), cheA AG2 (panel C), 
cheAG1 (panel D), or cheAG1/G2 (panel E) produced a serine band that 
A cheA B cheAG2 cheAt1.G2 
cheAG1 E cheAG1/G2 
Fig 13. Photographs of swarm plates demonstrating that allele cheAG2 
confers a dominant-negative phenotype in a wild-type background. Cells 
of the wild-type strain RP437 were transformed with: (A) pAR1 .cheA, (B) 
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pAR1 .cheAG2, (C) pAR1 .cheMG2, (D) pAR1 .cheAG1, and pAR1 .cheAG1/G2 
(E). The transformants were grown to mid-exponential phase in TB and spotted 
ontothe center of replicate (x5) tryptone agar plates containing 0.2% agar, 25 µM, 
IPTG and incubated at 320c. The displacement of their outermost swarms were 
compared after 6 hrs. 
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Fig 14. Displacement of the outermost serine band plotted as a function of 
time demonstrating the effect of overexpressing plasmid-borne CheA variants 
transformed into wild-type cells. cheA mutant catalytic alleles (each carried by the 
IPTG-inducible vector pAR1) were transformed into the wild-type background RP437. 
Cultures of each strain were inoculated into TB and grown at 320c with aeration 
to an O.D.610 of 0.3. Cells were inoculated onto replicate (x5) TB plates containing 
( 6) 0, ( •) 25, ( 'v) 50, or ( ♦) 100 µM IPTG and the displacement of their 
outermost bands compared over time. Wild-type cells transformed with the IPTG 
inducible vector expressing: (A) cheA, (B) cheAG1, (C) cheA.1G2, (D) cheAG2, 
(E) cheAG1/G2, (F) cheA2FW, and (G) cheA2FY. 
migrated at rates of approximately 0.22 cm hr -1, 0.28 cm hr1, 0.23 cm hr1, or 
0.28 cm hr1 respectively. In contrast, cells transformed with allele cheAG2· 
(Panel B) migrated very slowly relative to the other mutants (0.08 cm hr1). 
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To determine whether increased expression of any of the CheA variants 
could either produce or enhance enhance a dominant negative effect, this 
experiment was repeated using a range of IPTG concentrations ranging from 0 
to 100 µM. 
Overexpression of the wild-type cheA allele in a wild-type background 
decreases the migration rate in a dose-dependent fashion (Panel A). The 
mutant cheA alleles cheAG1 (Panel B) and cheAG1/G2 (Panel E), when 
overexpressed in a wild-type background, decrease migration rate in a manner 
similar to that observed for overexpression of wild-type cheA. In contrast, 
overexpression of the mutant allele cheAG2 (Panel D) exerts a more 
pronounced effect on migration rate than observed with overexpression of 
either cheAG1, cheAG1/G2 or cheA. CheA~G2 reduces migration rate less 
than overexpressed wild-type cheA. Finally, allelescheA2FY and cheA2FW 
seem to exert no effect at all upon migration rate, even when induced at 100 µM 
IPTG. 
Thus, the allele cheAG2 has a dominant-negative effect upon chemotaxis. 
In contrast, both cheA2FY and cheA2FW are recessive mutations. Alleles 
cheAG1, cheAG1/G2, and cheA~G2 exert a limited effect upon chemotaxis. 
In Vitro Autophosphorylation Analysis of CheA Variants Defective in 
G1, F orG2 
Mutations in the transmitter domain of CheA, which alter the conserved 
subdomains comprising the putative catalytic site, eliminate the ability to 
perform chemotaxis. A catalytic site is distinguished by its ability to bind and 
hydrolyze ATP. If the G1, F, and G2 subdomains comprise the catalytic site of 
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CheA, then CheA variants defective in these regions should fail to autophosphorylate. 
To test this hypothesis, I purified each CheA variant and analyzed them for their 
ability to autophosphorylate in vitro. 
I performed autophosphorylation experiments on wild-type CheAL' wild-
type CheA5 , and each mutant protein. Wild-type CheAL, wild-type CheA5 and 
the CheAL mutant proteins CheAL G 1, CheAL G 1 /G2, CheAL G2, CheAi:1G2, 
CheAL2FY, and CheAL48HQ, were purified to near homogeneity, as judged by 
SOS/PAGE (Fig 15). To ensure that the purified proteins were variants of CheA, 
western analysis was performed with CheA-specific antibody (data not shown). 
To assess the ability of the CheA variants to autophosphorylate, I added 
[y-32P]ATP to purified preparations of wild-type CheAL' wild-type CheA5 and 
each mutant protein. At the conclusion of a 5 min labeling period at room 
temperature, the reaction was terminated by the addition of 3X SOS/PAGE 
sample-loading buffer, the proteins separated by SOS/PAGE, and the 
radioactive bands detected by autoradiography (Fig 16). As expected, the 
reaction mixture containing only wild-type CheAL (lane 1) resulted in a 
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Fig 15. Purified variant CheA proteins. Proteins were isolated from cells of 
strain BL21 (OE3) transformed with various CheA expression vectors, bound 
and eluted from His-bind resin, separated by SOS-PAGE (10% gel), and 
detected by Coomassie blue staining. Lane (1) wild-type CheAL, lane (2) 
wild-type CheAs, lane (3) CheALG1 , lane (4) CheALG1/G2, lane (5) CheALG2, 
lane (6) CheALL\G2, lane (7) CheAL2FY, and lane (8) CheAL48HQ. Following 
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each purification, all proteins were confirmed for purity by SOS-PAGE analysis. 
The image was derived by scanning a photograph of the resultant gel with a 
Hewlett-Packard Scanjet model lie. 
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incubated with 50µM [y-32P]ATP (~2500 cpm pmol-1) in TKMD buffer (see 
Materials and Methods), the reactions were terminated by the addition of 3X 
SOS-PAGE sample buffer, and the samples were analyzed by SDS/10% PAGE 
followed by autoradiography for 60 min. Lane 1, wild-type CheAL; lane 2, 
wild-type CheAs; lane 3, CheALG1; lane 4, CheALG2; lane 5, CheALG1/G2; lane 
6, CheAL2FY; lane 7; CheAL48HQ; and lane 8, CheAL L\G2. 
The image was derived by scanning a photograph of the resultant gel with a 
Hewlett-Packard Scanjet model lie. 
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radiolabeled protein of MW about 78-kDa. in contrast, the reactions containing 
the following CheA variants did not result in such a band: CheA8 (lane 2), 
CheALG1 (lane 3), CheALG2 (lane 4), CheALG1/G2 (lane 5), CheAL2FY (lane6), 
CheAL 48HQ (lane 7), or CheAL LiG2 (lane 8). Thus, unlike wild-type CheAL, 
wild-type CheA8 and the mutant proteins did not autophosphorylate. 
ATP Binding 
On the basis of sequence homology with ATP binding motifs identified in 
eukaryotic serine/threonine kinases, Parkinson and Kofoid (1992) proposed 
the glycine-rich regions of the transmitter domain to be the site of ATP binding. 
However, no study has identified conclusively that this region actually binds 
ATP. My first attempt to address this problem ended in failure. I attempted to 
cross-link [a-32P]ATP to CheA using UV light. The resulting adducts were 
separated by SOS-PAGE and visualized by autoradiography. All of the 
proteins, both wild-type and mutant forms, seemed to bind ATP ( data not 
shown). To determine if such binding was specific or not, I attempted to 
interfere with the ability of wild-type CheA to bind [a-32P]ATP by pre-incubating 
CheA with 100-fold excess non-radioactive ATP. This excess unlabeled ATP 
failed to eliminate labeled ATP binding. I concluded that this method may 
encourage non-specific binding of ATP. 
Subsequently, we established a collaboration with Richard Stewart 
(University of Maryland). To determine if mutagenesis of the putative catalytic 
domain had an effect on nucleotide binding, the fluorescent ADP analog, TNP-
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ADP, was titrated against 10 µM of wild-type CheA and that of CheAL G 1, 
CheALG2, CheALG1/G2 or CheAL~G2. (according to the method of White and 
Dewey, 1987). The increase in fluorescence was measured and the data 
plotted as fluorescent intensity as a function of TNP-ADP concentration of the K0 
calculated (Table 4). The mutants CheALG1 or CheALG2, CheALG1/G2, and 
CheAL~G2 bound TNP-ADP with a significantly reduced affinity relative to that 
of wild-type CheAL (K0 of 60 µM, 110 µM, 16 µM, and 5 µM respectively). In 
contrast, CheAL G2 bound TNP-ADP about as well as wild-type CheA (K0 of 6 
µM). 
Thus, the G 1 region of CheA appears to be intimately involved in nucleotide 
binding whereas the G2 region does not. 
The Non-Phosphorylatable Variants CheA:S and CheA.L 48HQ can Mediate 
Transphosphorylation of Kinase-Deficient CheA.L Mutants In Vitro 
To assess the ability of the non-phosphorylatable CheA variants, CheA8 
or CheAL 48HQ, to promote phosphorylation of the CheA putative catalytic 
mutants CheAL G 1, CheAL G2, CheAL G 1 /G2 and CheAL ~G2, [y-32P]ATP was 
added to purified preparations of wild-type CheAL or wild-type CheA8 or each 
mutant protein which had been pre-incubated for 30 min in the presence of 
either CheA8 or CheAL 48HQ. At the conclusion of a 30-min labeling period at 
room temperature, the reaction was terminated by adding 3X SOS-PAGE 
Table 5.--TNP-ADP binding affinities of 
CheAL proteins 
Protein Ko 
CheAL(WT) 5µM 
CheALG1 60µM 
CheALG2 6µM 
QieALG1/G2 110 µM 
CheAL~G2 16µM 
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sample-loading buffer and the results analyzed by SOS-PAGE and 
autoradiography. Reactions containing wild-type CheAL alone or both CheA8 
and any of the following CheA mutants resulted in a radiolabeled protein of MW 
about 78-kDa: CheALG1 (lane 1), CheALG2 (lane 2), CheALG1/G2 (lane 3) and 
CheAL~G2 (lane 4). In contrast, reactions containing only CheA8 did not. 
Interestingly, reactions performed with CheA8 repeatedly resulted in more 
radiolabeled CheALG1 or CheALG2 (about 6% of wild-type levels) than 
radiolabeled CheAL G 1 /G2 or CheAL ~G2 (about 1.5% of wild-type levels). 
+ CheA5 (5 µM) 
5µM 
A 
+ CheAL 48HQ (5 µM) 
5µM 
B 
Fig 17. In vitro assays demonstrating that the non-phosphorylatable proteins 
CheAs (A) and CheAL 48HQ (B) can mediate transphosphorylation of kinase 
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deficient mutants of CheAL. CheA samples containing 5µM [final co-ncentration] 
of either CheAL or CheAs or both CheAs and each mutant protein or 
CheAL 48HQ and each mutant protein were pre-incubated for 30 min in TKMO 
buffer (see Materials and Methods) before the addition of 50µM [y-32 P]ATP 
(~2500 cpm pmol-1). The reactions were terminated after 30 min by the addition 
of 3X SOS-PAGE sample buffer and the samples were analyzed by SOS-PAGE 
(10%) followed by autoradiography for 60 min. Two radiolabeled bands were 
observed: one of about 78 kOa and a second, of about 30 kOa. Only the 78 kOa 
band is shown. Counts within this 78 kOa band were collected for 1 hr with a 
Betascope 603 blot analyzer within the linear range of the instrument. The 
experiment was performed 3 times. 
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Similarly, reactions containing both CheAL48HQ (Panel B) and each of the 
cheA mutants resulted in a radiolabeled protein MW 78 kOa. The intensity of 
the signal however, was substantially reduced compared to the levels observed 
for CheA8 . Again, the amount of radiolabelled CheAL G1 or CheAL G2 was 
greater than the amount of radiolabelled CheAL G 1 /G2 or CheAL ~G2 
To assess the ability of the mutant proteins CheAL G1 and CheAL G2 to 
promote phosphorylation of each other, I added [y-32P]ATP to purified 
preparations of wild-type CheAL alone, CheAL G1 alone, CheAL G2 alone, both 
CheAL G 1 and CheAL G2, or CheAL2FY alone that had been preincubated for 
30 min (Fig 18). At the conclusion of a 30-min labelling period at room 
temperature, the reaction was terminated by adding 3X SOS-PAGE sample-
loading buffer and the results analyzed by SOS-PAGE and autoradiography. In 
contrast to reactions containing wild-type CheAL alone (lane 1 ), those 
containing CheAL G1 alone (lane 2), CheAL G2 alone (lane 3), both mutant 
proteins together (lane 4), or CheAL 2FY alone did not result in a radiolabeled 
78-kOa protein. Reactions performed with both CheAL G 1 and CheAL G2 
together (Lane 4) resulted in very poor phosphorylation of a protein that 
migrated more slowly than wild-type CheAL. For several reasons, it seems 
unlikely that this band corresponds to a phosphorylated form of either CheAL G 1 
or CheAL G2 or of their 6XHis-tagged variants. First, the phosphorylated forms 
of CheAL G1 and CheAL G2 migrate with the same mobility as phosphorylated 
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wild-type CheAL. Second, after cleavage with thrombin, we detected no 6Xhis 
CheA variant by immunoblot analysis. Third, we detected no phosphorylation of 
the 6X-His tag itself when fused to either of the nonphosphorylatable proteins, 
CheA8 and CheAL 48HQ (data not shown). 
These results are consistent with a model by which the G1 and G2 
subdomains within the TR of one protomer of a CheA dimer form a unit that 
mediates transphosphorylation of the other protomer within that dimer. 
Interestingly, reactions involving CheAL G1 (lanes 2 and 4) yielded a 
radiolabeled protein fragment of MW about 30-kDa. We observed a 
phosphorylated fragment of similar molecular weight in reactions involving 
wild-type CheAL alone (lane 1) or the F mutant, CheAL 2FY (lane 5). To 
determine whether the observed fragments included the site of phosphorylation, 
His-48, we performed immunoblot analyses using anti-CheA (Fig 19a) or 
anti-CheAL antisera (Fig 19b). Wheras CheAL and the 30-kDa fragment 
reacted with both antisera (lanes 1 and 3 respectively), CheA8 reacted with only 
the anti-CheA serum (lanes 2). On the basis of its size (30kDa), 
immunoreactivity with antisera specific for an epitope unique to the P1 
domain, and the ability to accept a phosphoryl group, I have concluded that this 
degradation product corresponds to a previously reported CheA fragment 
composed of the N-terminal P1 and P2 domains (Oosawa et al., 1988). 
Thus, although the G1 and F mutants cannot autophosphorylate, they seem 
to be able to mediate transphosphorylation of the P1 -P2 fragment. · In contrast, 
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Fig 18. Phosphorylation of CheAL variants. CheA samples (each protein at 5 
µM [final concentration]) were pre-incubated for 30 min in TKMO buffer (see 
Materials and Methods) before the addition of 50µM [y-32P]ATP ( ~2500 cpm 
pmol-1). The reactions were terminated by the addition of 3X SOS-PAGE 
sample buffer and the samples were analyzed by SOS-PAGE (10% gel) 
followed by autoradiography for 60 min. Lane 1, wild-type CheAL; lane 2, 
CheAL G 1; lane 3, CheAL G2; lane 4, CheAL G 1 and CheAL G2; lane 5, 
CheAL2FY. Arrow indicates position of 30 kOa degradation product. The image 
was derived by scanning autoradiographs with a Hewlett-Packard Scanjet 
model lie. 
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Fig 19. lmmunoblot analyses using antisera specific for CheAL and CheAs 
(A) or CheAL alone (B) as primary antibodies. (A) lane (1 ), 6XHis-CheAL; 
lane (2), 6XHis-CheAs; lane (3), 6XHis-CheAL incubated at room 
temperature for 5 days at room temperature. (B) Lane (1 ), 6XHis-CheAL; 
lane (2), 6XHis-CheAs, lane (3), 6XHis-CheAL incubated at room 
temperature for 5 days to permit degradation and reabsorbed over His-bind 
resin (Novagen) to enrich for P1 containing fragments. The image was 
derived by scanning the immunoblots with a Hewlett-Packard Scanjet model 
lie. r 
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Fig 20: Computer algorithm analysis of secondary structure of the 
transmitter domain of CheA. Secondary structure is expressed as (E) 
sheet, (C) coil , (L) loop, (H) helix, (T,S) turn. 
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the G 1 mutant seemingly cannot. 
Structure Averaging Algorithms 
In contrast to a number of serine/threonine kinases (Lima, et al. 1996, 
Owen, et.al. 1995; Emerson, et al. 1995; Owen, et al. 1995), there is little or 
no structural information about the putative catalytic domain of CheA. In the 
absence of such structural information, I made use of several structure 
averaging algorithms to derive information about the possible secondary 
structure of this domain (Fig 20). One of the algorithms, the PhD method, 
was used to test the accuracy of the program by comparison of the published 
NMR structures of the P1 and P2 domains with the predicted structure. The 
PhD method revealed a level of agreement of about 64%. 
CheA237-519 
The observation that the G2 mutation confers stability and solubility to 
CheA led to me to believe that this mutation might increase the solubility of 
the isolated transmitter domain, thereby enabling NMR spectroscopic 
analysis of this highly insoluble domain. To test this possibility, I generated 
a truncated CheA protein, by introducing an Nde I site into the linker region 
between domains P2 and T. This involved two amino acid substitutions 
(P236H, V237M) which, interestingly, had no effect upon chemotaxis when 
compared to wild-type (data not shown). Into this construct, I then introduced 
both the G2 mutation and a premature stop codon in the linker region 
between T and M. This construction, called pDECheA237-519 (pDE36), 
was subcloned into pET14b, expressed, purified, and concentrated to 6 
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mg/ml. Solubility, in the context of NMR spectroscopy, refers to the ability of 
the protein, in high concentration and in an appropriate buffer, to resist 
precipitation when incubated at room temperature. CheA237-519 was 
judged soluble by virtue of its ability to stay in solution at both room 
temperature and at 4°C overnight when at a concentration of 6 mg/ml. The 
pDE36 construction was sent to Rick Dahlquist (University of Oregon) and is 
currently being assessed by Megan McEvoy (University of Oregon) as a 
candidate for NMR spectroscopy. If successful, this would be the first NMR 
spectroscopic analysis of a histidine kinase transmitter domain. Other, more 
conservative mutations in G2 are being generated in an attempt to mimic the 
degree of solubility observed in the G2 mutant. The enhanced stability and 
solubility of CheAL G2 and its ability to bind ATP with about wild-type affinity, 
has led us to consider it as a candidate for x-ray crystallography. 
CHAPTER 5 
DISCUSSION AND SUMMARY 
To identify regions of the CheA transmitter domain required to perform its 
catalytic activity, I constructed a select group of CheA mutants. I tested each of 
the mutants for their ability to perform chemotaxis in vivo and to 
autophosphorylate and/or to be transphosphorylated in vitro. Finally, I 
measured the ability of a subset of these mutants to bind ATP and/or to facilitate 
clustering of ternary complexes. 
Mutagenesis Strategy 
There are few studies that explore the relationship between structure and 
function of the putative catalytic regions of two-component histidine kinases. 
Since the putative catalytic domain of such kinases are insoluble at high 
concentrations, x-ray crystallographic and NMR spectroscopic studies to 
determine the structure have not been possible. Therefore, I used mutations as 
a tool to hypothesize about what this region of CheA might look like and how it 
functions. 
The G 1 and G2 regions of CheA resemble the kinase 2 and kinase 1 
regions of several bacterial kinases (Matte et al., 1996; Muller and Schulz, 
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1993; Reinstein et al, 1990; and Rose et al., 1991 ). Glycines are known to react 
with the nucleotides AMP and ATP (Yoneya et al., 1989). The consensus 
kinase 1 motif of E. coli phosphoenolpyruvate kinase (PCK) and adenylate 
kinase is G-X-X-G-X-G-K-T. This closely resembles the GXGXG motif of the G2 
subdomain of CheA. The kinase 2 region contains the consensus motif 
X-X-X-X-D (L-I-G-D-D in PCK) (Traut, 1994). The conserved "D" forms a Mg2+ 
binding site in conjunction with one of the hydrophobic "X" residues (Matte et 
al., 1996). The kinase 2 region of these proteins closely resemble the G1 
region of CheA (DDGAG), except that the "D" residue in CheA is N-terminal 
rather than C-terminal. 
We decided that the best mutation was one which should exert little 
structural impact on the region of interest, while changing the ability of that 
reactive amino acid to interact with either its nucleotide or other functional 
components of the putative catalytic domain. For instance, changing a 
phenylalanine to a tyrosine maintains the aromatic nature of the amino acid but 
adds a reactive hydroxyl group to the aromatic ring. This type of strategy has 
been used previously to determine the identity of amino acids reactive to the a, 
~. and yphosphoryl groups of ATP (Bazaes et al., 1993, 1995). 
Mutations in ATP binding regions which change glycine to some other 
residue have repeatedly been shown to alter catalytic function in kinases 
(Yoneya et al., 1989; Ninfa et al., 1993). We chose to change conserved 
glycines in the G 1 and G2 subdomains of CheA because this change presented 
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the least possibility of causing structural alterations in the region. A change 
from glycine to alanine replaces the reactive H with a methyl group but 
maintains the aliphatic identity of this residue. Despite proline being "aliphatic-
like", it was eliminated as a possible replacement for the glycine residues 
because the G1 and G2 regions are predicted to be flexible loops and the rigid 
backbone of proline could have perturbed the interaction of these putative loops 
with neighboring structures. Three crystallographic studies and one functional 
study performed on conserved glycine residues in the nucleotide binding 
regions of E. coli adenylate kinase reinforce the decision to replace glycine 
residues with alanines. Muller and Schulz (1993) demonstrated that 
replacement of glycine-10 with valine hinders the induced fit movements of the 
active site. This suggests that this type of substitution could perturb structure in 
an ATP binding loop. Reinstein et al. (1990) clearly showed that a glycine-10 to 
valine substitution has an increased dissociation constant for substrate and 
structural alterations in the nucleotide binding site. Rose et al. (1991) showed 
that a glycine 85 to valine substitution in the kinase-2 region of E. coli 
adenylate kinase caused a decrease in the thermodynamic stability of the 
protein. Finally, Yoneya et al. demonstrated that a glycine 15 to alanine or a 
glycine-20 to alanine substitution in E. coli adenylate kinase decreased the 
affinity of the kinase-1 region for AMP and ATP. 
Chemotaxis Requires Intact G1. F. and G2 Subdomains 
The mutations 422GA, 455FY/459FY, 455FW/459FW, 
470GA/472GA/474GA and ~(468-476), located within the highly conserved G1, 
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F, and G2 regions of the histidine kinase CheA, each eliminated the ability of 
cells to perform chemotaxis. The G2 mutation 470GK also eliminates 
chemotaxis (Oosawa et al., 1988). Mutations in G1, F, and G2 in other histidine 
kinases yield similar results. For example, a mutation in the G2 region of NRII 
reduces the ability of cells to activate expression of glnA (Ninfa et al., 1993). 
Similarly, a mutation that deletes the F and G2 regions of DctB eliminates the 
ability of that protein to functon in vivo (Giblin et al., 1996). 
Autophosphorylation Requires Intact G1, F. and G2 Subdomains 
To determine why these mutant alleles failed to support chemotaxis in 
vivo, I measured the ability of each purified mutant protein to 
autophosphorylate. In contrast to wild-type CheAL' none of the putative 
catalytic mutants tested autophosphorylated when incubated in the presence of 
[y-32P]ATP for up to 30 minutes. Other researchers also have shown that 
mutations in the conserved subdomains inhibit the ability of CheA and other 
histidine kinases to autophosphorylate. Mutations which truncate the catalytic 
domain at either the 503'rd position or change residue G470 to a K eliminate 
the ability to autophosphorylate (Wolfe and Stewart, 1993; Swanson et al., 
1994). Similarly, mutations that truncate the F and G2 regions of DctB (Giblin et 
al., 1996) and those that alter the G2 domain of NRII severely perturb the ability 
of these proteins to autophosphorylate (Ninfa et al., 1993). 
The CheALG2, CheAL~G2, and CheALG1/G2 mutants were more stable 
than the wild-type CheAL protein. In contrast, the CheAL G1 mutant was less 
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stable than wild-type CheAL. Thus, the lack of stability in these mutants could 
account for the inability of CheAL G 1 to autophosphorylate and mutant cells 
expressing this protein to perform chemotaxis. In the case of the CheAL G 1 
mutant however, this is unlikely because CheA8 can mediate 
transphosphorylation of CheAL G 1. The same cannot be said for the F mutants. 
In contrast to CheAL G 1 and in particular CheAL G2 and CheAL LiG2 the F 
mutants were very unstable in vitro. The lack of autophosphorylation may be an 
artifact of such instability. 
Since purification of CheA and variants of CheA involves the absorption 
of a total cell lysate of BL21 (DE3), an E. coli strain, phosphatases to CheA such 
as CheB or CheY could have co-precipitated with CheA in the eluate, despite 
stringent washing of the Ni2+ absorption column. Autophosphorylation 
experiments performed with fresh preparations of wild-typeCheA, however, 
revealed no radiolabelled bands corresponding to the molecular weights of 
CheB or CheY. Similarly, no contaminating bands were ever observed upon 
SOS-PAGE analysis of freshly purified preparations of CheA and variants of 
CheA. Despite these observations, it is possible that very small quantities of 
CheY and CheB contaminants were in the purified preparations of CheA and 
CheA variants. The level of disparity of phosphorylation between wild-type 
CheA and CheA variants, however, demonstrates that whatever influence the 
possible contaminants had on the ability of the CheA variants to 
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autophosphorylate was minimal. Thus, we conclude that the inability of G1 and 
G2 mutants to perform chemotaxis likely results from their inability to 
autophosphorylate. 
G1 Residue G422 Plays an Intimate Role in Binding of ATP: G2 Residues G470, 
G472, and G474 do not 
To autophosphorylate, CheAL must first bind ATP. Therefore, quantitative 
nucleotide binding studies were performed on the G 1 , G2. G 1 /G2 and ~G2 
mutants of CheAL. Intriguingly, CheAG2 bound TNP-ADP about as well as wild-
type. In contrast. CheAL G1 bound TNP-ADP poorly. 
However, we conclude that G 1 is intimately involved in the binding of 
adenine-containing nucleotides. Conversely, we can conclude that G2 is not. 
Evidence exists, however, that this latter region may play a secondary role in 
such binding. The CheAL ~G2 mutant has had all of the conserved residues 
removed, including those flanking the conserved glycines. In contrast. the 
CheALG1/G2 mutant retains the conserved residues flanking G2. If the G1 
region was solely responsible for binding TNP-ADP, then one might expect that 
the level of nucleotide binding in the ~G2 region would approximate that 
observed in the G2 mutant. In addition, the double CheAL G1/G2 mutant might 
also be expected to bind nucleotide with about the same affinity as CheAL G 1 . 
This is not the case. Both CheAL~G2 and CheALG1/G2 bound TNP-ADP with a 
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lower affinity than predicted. These reduced binding affinities suggest two 
possibilities. Either the G2 region contains other conserved residues (perha·ps 
those flanking it) which could be involved in nucleotide binding or these 
mutations cause structural perturbations by not allowing nucleotide-binding 
residues in G2 to interact with the remaining nucleotide-binding residues in G 1 . 
Secondary structure prediction methods (see below) suggest that the in-frame 
removal of nine amino acids in the CheAL ~G2 mutant would eliminate a 
predicted G2 loop structure and render the region from F through the the G2 
region a helix. This suggests that a structural perturbation and the removal of 
critical nucleotide-binding residues may be responsible for the reduced 
nucleotide-binding observed in this mutant. 
The interpretation of these results must take into account that the affinity 
of CheA for TNP-ADP is significantly greater than the affinity of CheA for ADP or 
ATP (K0 5 µM, 50 µM, or 300 µM respectively). This fact must be taken into 
account when considering this data. In the absence of ATP competition 
binding experiments, we cannot draw any conclusions concerning binding 
affinity of these mutants for nucleotide. 
G2 Residues G470, G472. and/or G474 Play a Role in either the Docking of P1 
and/or the Subsequent Phosphotransfer: G1 Residue G422 and F Residues 
F455 and F459 do not 
To autophosphorylate, CheA must facilitate the interaction between 
bound ATP, the site of phosphorylation, and phospho-transfer. The P1 domain 
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receives its phosphate from the catalytic site. Autophosphorylation experiments 
demonstrated that the catalytic domains of the unstable G 1 and F mutants 
efficiently transphosphorylated a 30 kDa degradation product comprised of the 
P1 and P2 domains even though full length protein could not 
autophosphorylate. Since the G 1 and F mutant proteins transphosphorylate the 
P1-P2 fragment, the ability of these proteins to interact with P1 must not be 
significantly affected. In contrast, the G2 mutant could not transphosphorylate 
the degradation product. The apparent inability of this mutant protein to 
transphosphorylate the 30 kDa degradation product could be explained if the 
G2 mutation conferred gross structural defects. This is unlikely, however, since 
CheAL G2 binds ATP as efficiently as wild-type CheA. Thus, the G2 region may 
play a role in docking of the P1 domain to the catalytic site. Alternatively, it 
could function in subsequent phosphotransfer. At present, I cannot distinguish 
between these two possibilities. However, the fact that G2 seemingly is not 
required for nucleotide binding yet seemingly is necessary for subsequent 
events suggests that G1 and G2 each play different roles in the catalytic 
process. 
Clustering of Ternary Complexes Requires an Intact G2 Subdomain, but not a 
G 1 Subdomain 
Intriguingly, mutants defective in G2 do not form polar aggregates (J. 
Maddock, personal communication). The lack of aggregates resembles that of 
mutants entirely lacking CheA, CheW, or MCPs. The simplest explanation for 
these results is that G2 does not form ternary complexes. At present, this is only 
a hypothesis. Careful in vitro binding studies will be required to establish 
whether CheAL G2 can couple into a ternary complex. In contrast, mutants in 
the G1 subdomain do form aggregates. Therefore, the G1 mutant must form 
ternary complexes. 
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Ternary complex formation in vivo must not be closely associated with 
the ability to bind ATP. The G1 mutant binds TNP-ADP poorly yet forms ternary 
complexes, while the G2 mutant binds TNP-ADP well yet does not form ternary 
complexes. These in vivo results fit well with the observation by Gegner et al. 
(1992) that ATP is not necessary for ternary complex formation in vitro. 
These observations could be explained if the G2 subdomain is one of the 
sites through which the ternary complex affects the hydrolysis of ATP and the 
subsequent phosphotransfer by bringing G2 close to G 1 to form a functional 
catalytic site. If G2 is a docking site for the P1 domain, then this arrangement 
would make sense. This is only speculation, however, and there could be 
alternate explanations for these results. This hypothesis could be tested, in 
part, by performing studies which quantitate the binding affinity of the 30 kDa 
P1/P2 domains for each of the mutants and comparing that to the binding affinity 
of the P1/P2 domains for wild-type CheA. An interesting experiment might be to 
do the binding studies in a ternary complex composed of each catalytic mutant, 
CheW, and chemoreceptor cytoplasmic domains which have their methylation 
sites altered to place the ternary complex in the "on" or "off " states. If G2 is a 
docking site for the P1 domain, then a chemoreceptor in the "off" state might 
have a lower affinity for the P1 domain since the docking site would be 
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sequestered. 
G1 and G2 Function in cis 
CheA functions as a dimer (Surrette et al., 1996). The P1 domains of 
each protomer obtain their phosphate in trans from their dimer partner (Wolfe 
and Stewart, 1993). There are two possible ways in which the G1, F, and G2 
subdomains of the transmitter domains in a CheA dimer could function. First, 
they could function in trans. That is, they could each contribute subdomains to 
form one functional catalytic unit. Second, they could function in cis as 
structurally independent catalytic subunits. 
I performed a series of in vitro complementation experiments in which 
purified preparations of several CheA catalytic mutant proteins were mixed 
together and their respective levels of phosphorylation assayed in the presence 
of [y-32P]ATP. Additionally, I performed a series of in vivo experiments in which 
various catalytic mutants of CheA , placed in single copy on the chromosome, 
were complemented with a wild-type catalytic domain provided by CheA5 . 
In vitro, the short form of CheA transphosphorylated all of the CheAL 
catalytic domain. The level of transphosphorylation by CheA5 of the CheALG1 
and CheAL G2 mutants was about 6% that of wild-type CheAL 
autophosphorylated under the same conditions. In contrast, the level of 
transphosphorylation of CheAL G 1 /G2 or CheAL ~G2 was about 1 % that of 
wild-type CheAL. In vivo, CheA5 complemented only variants mutated in G1 or 
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G2 alone. It could not complement the double mutation (CheAL G 1 /G2) or the 
mutation in which the entire G2 region has been removed in-frame. The 
inability of these latter mutants to be complemented in vivo is likely to be due to 
the low level of CheA8-mediated phosphorylation observed in vitro. The 
disparity between the levels of phosphorylation required for CheA8-mediated 
chemotaxis and the wild-type levels of phosphorylation in vivo seems to 
indicate that a minimum threshold of phosphorylation is required to drive 
chemotaxis. Evidence exists for such a phenomenon: a P1 deletion mutant can 
be complemented in trans only if P1 is provided in excess (Garzon and 
Parkinson, 1996). If the level of phosphorylation drops below that minimum 
threshold, then the efficiency of phospho-transfer to CheY, even when the 
mutant protein is bound into the ternary complex, is too low to mediate 
chemotaxis. If the level of phospho-CheY is too low to overcome spontaneous 
degradation or CheZ-mediated dephosphorylation, the cells will rarely tumble. 
The predominately smooth swimming behavior of these mutants has been 
confirmed by light microscopy under a variety of induction conditions. 
In vivo, CheAL G1 and CheAL G2 could not complement each other. In 
vitro, the combination of CheAL G 1 and CheAL G2 resulted in a poorly 
phosphorylated product that migrated slightly slower than the 
78 kDa full length wild-type CheA protein. For several reasons, it seems 
unlikely that this band corresponds to a phosphorylated form of either CheAL G 1 
or CheAL G2. First, the phosphorylated forms of CheAL G1 and CheAL G2 
migrated with the same mobility as wild-type CheAL. Second, after cleavage 
with thrombin, no 6XHis-CheA variant was detected by immunoblot analysis. 
Third, we detected no phosphorylation of the 6XHis tag itself when fused to 
either of the non-phosphorylatable proteins, CheAs, or CheA48L HQ. 
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These results are consistent with a mechanism by which the G1 and G2 
subdomains within the TR of one protomer of a CheA dimer form a unit that 
mediates transphosphorylation of the other protomer within that dimer. This 
model easily reconciles with that of Tawa and Stewart (1994) who 
demonstrated that at least one residue (i.e., 337P) in the TL of the protomer that 
becomes phosphorylated helps to determine the binding affinity of CheA for 
ATP. One can envision a model in which the TL of one protomer interacts with 
the TR of the second protomer within the dimer to modulate ATP-binding and 
hydrolysis. 
Secondary Structure Prediction and Model for the Structure of the Catalytic 
Domain of the Histidine Kinase CheA 
Secondary structure algorithms, while far from perfect as a replacement 
for structural visualization methods such as NMR spectroscopy and 
x-ray-crystallography, can be helpful when trying to correlate data derived from 
in vitro and in vivo analysis to functional models. With this kind of knowledge in 
hand, an initial test can be performed which allows a researcher to generalize 
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about what the secondary structure of any particular protein may look like. As an 
initial analysis, these algorithms take short stretches of amino acids (approx. · 
30 aa or smaller) and attempt to find similar structures within proteins that have 
already been crystallized. The protein data bank (PDB) contains the three 
dimensional structures of several hundred proteins. Many proteins are highly 
flexible, assuming different shapes in the presence or absence of antigen, 
ligands, metals, or nucleotides. This type of structural mobility has been 
observed when crystallographic structures were compared between different 
binding states. When protein motifs on file in the PDB are found to be 
homologous to the protein being analyzed, the predictions derived from 
algorithms such as these can be quite accurate. Using the CheA primary amino 
acid sequence as a template, I used several algorithms in an attempt to derive 
secondary structure information over the entire protein. Since it is the focus of 
this study, the putative ATP binding region of transmitter domain was of 
particular interest. To predict the secondary structure of this region, 5 different 
algorithms were utilized (Gilbrat et al., 1987, Levin et al., 1986, Deleage and 
Roux, 1987, Rost and Sander, 1994, Geourjon and Deleage, 1995). Based 
upon such factors as sequence homology, side chain associations, and solvent 
accessibility, a consensus of the methods predicts that G1, F, and G2 resemble 
coils and turns (loops). In a separate secondary structure analysis of this region 
using only the PhD prediction method, these regions are predicted to be 
unstructured loops, consistent with observations of the crystallographic structure 
of several different eukaryotic ATP binding regions. F is flanked by alpha 
helices and sheets that suggest a bend, As a reference for the accuracy of 
prediction of each of these methods, the predictions were compared to the 
deduced structure of the N-terminal domains P1 and P2 of CheA. These 
domains have undergone rigorous analysis by NMR and their 2° and 3° 
structures are known. 
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On the basis of these structure-averaging algorithms, we propose that the 
catalytic region is best represented as a cleft in which the F subdomain lies at 
the base and acts as a flexible turn or hinge flanked by two short alpha helices 
(Fig 20). This arrangement would serve to approximate G1 and G2, predicted to 
be unstructured ATP-binding loops (Rossman and Liljas, 1974). The binding of 
ligand by the chemoreceptor would initiate a cascade through the ternary 
complex with the end result being the movement of the G1 and G2 loops apart, 
rendering CheA in an inactive conformation. Release of ligand would remove 
this repression permitting the catalytic domain to return to the active 
conformation in which G 1 and G2 properly align relative to one another. 
Significance of Other Histidine Kinases that lack Some of the 
Conserved Regions 
In undertaking this study, I was interested in defining the structure and 
function of a little understood region of the histidine kinase CheA. Although this 
study was concerned with the putative catalytic domain of one protein, the 
motifs which define CheA as a histidine kinase are shared by many other 
proteins. Over 100 two-component histidine kinases have been identified in 
bacteria. Several have also been identified in eukaryotes and plants (Ota and 
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Fig 21. Model for the structure of the G1 - G2 region of the transmitter domain of 
CheA. The catalytic site is represented in this model as two ATP binding loops 
(G1 and G2) separated by two beta-pleated sheets and a bend at the F box. 
The site is in an "active" form when the two loops are allowed to approximate 
into a single, functional catalytic site. The catalytic site is in an "inactive" form 
upon dissociation of G 1 and G2. 
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Varshavsky, 1993 Chang, et.al., 1993) suggesting that this type of kinase is not 
unique to either prokaryotes or even to single-celled organisms. Structural 
information about the catalytic region of any histidine kinase is a much desired 
goal of many different groups of researchers. In addition to its obvious 
intellectual value, catalytic domain structural information has enormous 
potential forpractical value as well. Since the general catalytic motif of histidine 
kinases has mostly been observed in bacteria, a number of which are 
pathogenic to humans and animals, it has important potential as 
a therapeutic target. Several companies, including one our lab has been in 
collaboration with, are interested in designing drugs which would interfere with 
the function of this domain. 
Not all putative catalytic domains of histidine kinases have the N, G1, 
F, G2 arrangement of all four catalytic subdomains. The nitrate/nitrite sensor 
protein NarX, for instance, lacks both the F and G2 regions. Yet, it mediates 
phosphorylation and dephosphorylation of the response regulator NarL 
(Schroder et al., 1994; Chiang et al., 1992). The Bacillus subti/us histidine 
kinase DegS also lacks the G2 region. In addition, its F subdomain seems to be 
in the orientation opposite to that of the conventional histidine kinase motif. It 
too can mediate phosphorylation of a response regulator DegU (Hanner et al., 
1988). 
The absence of catalytic motifs in these other histidine kinases should be 
noted since they may help us understand the function of particular subdomains. 
Clearly, further structure-function investigations such as this are necessary. 
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